Menu

Wolfson Institute of Preventive Medicine

Search - ZOO
Search - K2
Search - Categories
Search - Contacts
Search - Content
Search - Newsfeeds
Search - Weblinks

Publications

We maintain an archive of past and current publications which can be searched by clicking on the links to the left or by using the drop down menus at the top of this page to search by author name, journal name or year of publication.

Alternatively you can use the search bar to look up a key word.

Our most recent publications are listed below.

Stephen Duffy Publications

Authors

Publication Summary

Journal

Years

Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N, Mascalchi M, Delorme S, Baldwin DR, Callister ME, Becker N, Heuvelmans MA, Rzyman W, Infante MV, Pastorino U, Pedersen JH, Paci E, Duffy SW European position statement on lung cancer screening. vol.18, (12) e754 - e766.
10.1016/S1470-2045(17)30861-6
The Lancet Oncology2017
Brown T, Dyck I, Greenhough B, Raven-Ellison M, Dembinsky M, Ornstein M, Duffy SW Fear, family and the placing of emotion: Black women's responses to a breast cancer awareness intervention.. vol.195, () 90 - 96.
10.1016/j.socscimed.2017.10.037
Soc Sci Med2017
Duffy SW, Morrish OWE, Allgood PC, Black R, Gillan MGC, Willsher P, Cooke J, Duncan KA, Michell MJ, Dobson HM, Maroni R, Lim YY, Purushothaman HN, Suaris T, Astley SM, Young KC, Tucker L, Gilbert FJ Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer.. vol.88, () 48 - 56.
10.1016/j.ejca.2017.10.022
Eur J Cancer2017
Tabar L, Chen TH-H, Yen AM-F, Chen SL-S, Fann JC-Y, Chiu SY-H, Ku MM, Wu WY-Y, Hsu C-Y, Chen Y-Y, Beckmann K, Smith RA, Duffy SW EFFECT OF MAMMOGRAPHY SCREENING ON MORTALITY BY HISTOLOGICAL GRADE.. vol., () .
10.1158/1055-9965.EPI-17-0487
Cancer Epidemiol Biomarkers Prev2017
Woznitza N, Devaraj A, Janes SM, Duffy SW, Bhowmik A, Rowe S, Piper K, Maughn S, Baldwin DR Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial.. vol.18, (1) 521.
10.1186/s13063-017-2268-x
Trials2017
Brain K, Carter B, Lifford KJ, Burke O, Devaraj A, Baldwin DR, Duffy S, Field JK Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.. vol.72, (10) 912 - 918.
10.1136/thoraxjnl-2016-209690
Thorax2017
Maxwell AJ, Michell M, Lim YY, Astley SM, Wilson M, Hurley E, Evans DG, Howell A, Iqbal A, Kotre J, Duffy S, Morris J A randomised trial of screening with digital breast tomosynthesis plus conventional digital 2D mammography versus 2D mammography alone in younger higher risk women.. vol.94, () 133 - 139.
10.1016/j.ejrad.2017.06.018
Eur J Radiol2017
Smith SG, Wardle J, Atkin W, Raine R, McGregor LM, Vart G, Morris S, Duffy SW, Moss S, Hackshaw A, Halloran S, Kralj-Hans I, Howe R, Snowball J, Handley G, Logan RF, Rainbow S, Smith S, Thomas M, Counsell N Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.. vol.17, (1) 543.
10.1186/s12885-017-3512-1
BMC Cancer2017
Atkin W, Wooldrage K, Sasieni P, Duffy SW, Cross AJ Colorectal adenomas, surveillance, and cancer. vol.18, (8) E428 - E428.LANCET ONCOLOGY2017
Atkin W, Wooldrage K, Sasieni P, Duffy SW, Cross AJ Colorectal adenomas, surveillance, and cancer - Authors' reply.. vol.18, (8) e428.
10.1016/S1470-2045(17)30532-6
Lancet Oncol2017
Nair A, Screaton NJ, Holemans JA, Jones D, Clements L, Barton B, Gartland N, Duffy SW, Baldwin DR, Field JK, Hansell DM, Devaraj A The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial.. vol., () .
10.1007/s00330-017-4903-z
Eur Radiol2017
Benton SC, Butler P, Allen K, Chesters M, Rickard S, Stanley S, Roope R, Vulkan D, Duffy SW GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.. vol.116, (12) 1551 - 1557.
10.1038/bjc.2017.129
Br J Cancer2017
Atkin W, Wooldrage K, Brenner A, Martin J, Shah U, Perera S, Lucas F, Brown JP, Kralj-Hans I, Greliak P, Pack K, Wood J, Thomson A, Veitch A, Duffy SW, Cross AJ Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study.. vol.18, (6) 823 - 834.
10.1016/S1470-2045(17)30187-0
Lancet Oncol2017
Sheringham J, Sequeira R, Myles J, Hamilton W, McDonnell J, Offman J, Duffy S, Raine R Variations in GPs' decisions to investigate suspected lung cancer: a factorial experiment using multimedia vignettes.. vol.26, (6) 449 - 459.
10.1136/bmjqs-2016-005679
BMJ Qual Saf2017
Allgood , MARONI R, Hudson S, Offman , Turnbull AE, Peacock L, Steel J, Kirby G, Ingram CE, Somers J, Fuller C, Threlfall AG, Gabe R, Maxwell AJ, Patnick J, Duffy SW The effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial. vol., () .
10.1016/S1470-2045(17)30340-6
Lancet Oncology2017
Tucker L, Gilbert FJ, Astley SM, Dibden A, Seth A, Morel J, Bundred S, Litherland J, Klassen H, Lip G, Purushothaman H, Dobson HM, McClure L, Skippage P, Stoner K, Kissin C, Beetles U, Lim YY, Hurley E, Goligher J Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography?. vol.283, (2) 371 - 380.
10.1148/radiol.2017151936
Radiology2017
Duffy SW, Etzioni R, Sasieni P Both a stage shift and changes in stage-specific survival have contributed to reductions in breast cancer mortality.. vol.22, (2) 76.
10.1136/ebmed-2016-110632
Evid Based Med2017
Atkin W, Wooldrage K, Parkin DM, Kralj-Hans I, MacRae E, Shah U, Duffy S, Cross AJ Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial.. vol.389, (10076) 1299 - 1311.
10.1016/S0140-6736(17)30396-3
Lancet2017
Atkin W, Brenner A, Martin J, Wooldrage K, Shah U, Lucas F, Greliak P, Pack K, Kralj-Hans I, Thomson A, Perera S, Wood J, Miles A, Wardle J, Kearns B, Tappenden P, Myles J, Veitch A, Duffy SW The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.. vol.21, (25) 1 - 536.
10.3310/hta21250
Health Technol Assess2017
Tabar L, Chen TH-H, Hsu C-Y, Wu WY-Y, Yen AM-F, Chen SL-S, Chiu SY-H, Fann JC-Y, Beckmann K, Smith RA, Duffy SW Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review.. vol.24, (1) 27 - 33.
10.1177/0969141316631375
J Med Screen2017
Yen AM-F, Wu WY-Y, Tabar L, Duffy SW, Smith RA, Chen H-H Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer.. vol.27, (3) 98 - 106.
10.1016/j.je.2016.10.003
J Epidemiol2017
Baldwin DR, Duffy SW, Devaraj A, Field JK Optimum low dose CT screening interval for lung cancer: the answer from NELSON?. vol.72, (1) 6 - 7.
10.1136/thoraxjnl-2016-209011
Thorax2017
Beruchashwili T, Gvamichava R, Duffy SW Screening organization and recall rate in a regional breast screening programme.. vol., () 969141317704680.
10.1177/0969141317704680
J Med Screen2017
Raine R, Moss SM, von Wagner C, Atkin W, Hans IK, Howe R, Solmi F, Morris S, Counsell N, Hackshaw A, Halloran S, Handley G, Logan RF, Rainbow S, Smith S, Snowball J, Seaman H, Thomas M, Smith SG, McGregor LM A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening.. vol.115, (12) 1479 - 1486.
10.1038/bjc.2016.365
Br J Cancer2016
Michalopoulos D, Duffy SW Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.. vol.23, (4) 192 - 202.
10.1177/0969141315623980
J Med Screen2016
Brain K, Lifford KJ, Carter B, Burke O, McRonald F, Devaraj A, Hansell DM, Baldwin D, Duffy SW, Field JK Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.. vol.71, (11) 996 - 1005.
10.1136/thoraxjnl-2016-208283
Thorax2016
Nair A, Gartland N, Barton B, Jones D, Clements L, Screaton NJ, Holemans JA, Duffy SW, Field JK, Baldwin DR, Hansell DM, Devaraj A Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial.. vol.89, (1066) 20160301.
10.1259/bjr.20160301
Br J Radiol2016
Niksic M, Rachet B, Duffy SW, Quaresma M, Møller H, Forbes LJ Is cancer survival associated with cancer symptom awareness and barriers to seeking medical help in England? An ecological study.. vol.115, (7) 876 - 886.
10.1038/bjc.2016.246
Br J Cancer2016
Hudson S, Brazil D, Teh W, Duffy SW, Myles JP Effectiveness of timed and non-timed second appointments in improving uptake in breast cancer screening.. vol.23, (3) 160 - 163.
10.1177/0969141315624937
J Med Screen2016
Field JK, Duffy SW, Devaraj A, Baldwin DR Implementation planning for lung cancer screening: five major challenges.. vol.4, (9) 685 - 687.
10.1016/S2213-2600(16)30233-8
Lancet Respir Med2016
Greenhough B, Dembinsky M, Dyck I, Brown T, Robson J, Homer K, Sajani C, Carter L, Duffy SW, Ornstein M Evaluating a DVD promoting breast cancer awareness among black women aged 25-50 years in East London.. vol.70, (7) 678 - 682.
10.1136/jech-2015-206540
J Epidemiol Community Health2016
Marcus MW, Raji OY, Duffy SW, Young RP, Hopkins RJ, Field JK Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model.. vol.49, (1) 361 - 370.
10.3892/ijo.2016.3499
Int J Oncol2016
Sasieni PD, Duffy SW, Cuzick J Ovarian cancer screening: UKCTOCS trial.. vol.387, (10038) 2602.
10.1016/S0140-6736(16)30847-9
Lancet2016
Butler P, Duffy S, Reed K, Chesters M, Stanley S, Rickard S, Roope R, Benton S GP PARTICIPATION IN INCREASING UPTAKE IN BOWEL CANCER SCREENING: THE PEARL PROJECT. vol.65, () A194 - A195.
10.1136/gutjnl-2016-312388.359
GUT2016
Douglas E, Waller J, Duffy SW, Wardle J Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap?. vol.23, (2) 98 - 103.
10.1177/0969141315600192
J Med Screen2016
Burnside ES, Sickles EA, Duffy SW A Pragmatic Approach to Determine Components of Optimal Screening Mammography Practice.. vol.315, (18) 1951 - 1953.
10.1001/jama.2016.4530
JAMA2016
Field JK, Duffy SW Lung cancer CT screening: is annual screening necessary?. vol.17, (5) 543 - 544.
10.1016/S1470-2045(16)00079-6
The Lancet Oncology2016
Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MKB, Rintoul RC, Screaton N, Wald NJ, Weller D The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. vol.20, (40) 1 - 146.
10.3310/hta20400
Health Technology Assessment2016
Duffy SW DCIS and invasive interval breast cancer - Author's reply.. vol.17, (3) e88 - e89.
10.1016/S1470-2045(16)00104-2
Lancet Oncol2016
Massat NJ, Sasieni PD, Tataru D, Parmar D, Cuzick J, Duffy SW Explaining the Better Prognosis of Screening-Exposed Breast Cancers: Influence of Tumor Characteristics and Treatment.. vol.25, (3) 479 - 487.
10.1158/1055-9965.EPI-15-0804
Cancer Epidemiol Biomarkers Prev2016
Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On.. vol.25, (3) 455 - 462.
10.1158/1055-9965.EPI-15-0803
Cancer Epidemiol Biomarkers Prev2016
Sasieni PD, Smith RA, Duffy SW Response to Hersch et al.. vol.23, (1) 56.
10.1177/0969141315613367
J Med Screen2016
Wardle J, von Wagner C, Kralj-Hans I, Halloran SP, Smith SG, McGregor LM, Vart G, Howe R, Snowball J, Handley G, Logan RF, Rainbow S, Smith S, Thomas MC, Counsell N, Morris S, Duffy SW, Hackshaw A, Moss S, Atkin W Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.. vol.387, (10020) 751 - 759.
10.1016/S0140-6736(15)01154-X
Lancet2016
Raine R, Duffy SW, Wardle J, Solmi F, Morris S, Howe R, Kralj-Hans I, Snowball J, Counsell N, Moss S, Hackshaw A, von Wagner C, Vart G, McGregor LM, Smith SG, Halloran S, Handley G, Logan RF, Rainbow S, Smith S Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.. vol.114, (3) 321 - 326.
10.1038/bjc.2015.413
Br J Cancer2016
Duffy SW, Dibden A, Michalopoulas D Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study (vol 17, pg 109, 2016). vol.17, (2) E46 - E46.LANCET ONCOLOGY2016
Field JK, Duffy SW, Baldwin DR, Whynes DK, Devaraj A, Brain KE, Eisen T, Gosney J, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MKB, Rassl DM, Rintoul RC UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.. vol.71, (2) 161 - 170.
10.1136/thoraxjnl-2015-207140
Thorax2016
Allgood PC, Maxwell AJ, Hudson S, Offman J, Hutchison G, Beattie C, Tuano-Donnelly R, Threlfall A, Summersgill T, Bellis L, Robinson C, Heaton S, Patnick J, Duffy SW A randomised trial of the effect of postal reminders on attendance for breast screening.. vol.114, (2) 171 - 176.
10.1038/bjc.2015.451
Br J Cancer2016
Field JK, Devaraj A, Duffy SW, Baldwin DR CT screening for lung cancer: Is the evidence strong enough?. vol.91, () 29 - 35.
10.1016/j.lungcan.2015.11.003
Lung Cancer2016
McGregor LM, von Wagner C, Atkin W, Kralj-Hans I, Halloran SP, Handley G, Logan RF, Rainbow S, Smith S, Snowball J, Thomas MC, Smith SG, Vart G, Howe R, Counsell N, Hackshaw A, Morris S, Duffy SW, Raine R, Wardle J Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial.. vol.2016, () 3670150.
10.1155/2016/3670150
Gastroenterol Res Pract2016
Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K, Hall C, Liao X-H, Ryan M, Johnson F, Stevens G, Kearins O, Sellars S, Patnick J Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.. vol.17, (1) 109 - 114.
10.1016/S1470-2045(15)00446-5
Lancet Oncol2016
Duffy SW The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy de Gelder R, Heijnsdijk EAM, Fracheboud J, et al (Erasmus Med Ctr, Rotterdam, the Netherlands) Int J Cancer 137:165-172, 2015. vol.27, (2) 126 - 128.
10.1016/j.breastdis.2016.04.003
Breast Diseases2016
Gilbert FJ, Tucker L, Gillan MGC, Willsher P, Cooke J, Duncan KA, Michell MJ, Dobson HM, Lim YY, Suaris T, Astley SM, Morrish O, Young KC, Duffy SW Accuracy of Digital Breast Tomosynthesis for Depicting Breast Cancer Subgroups in a UK Retrospective Reading Study (TOMMY Trial).. vol.277, (3) 697 - 706.
10.1148/radiol.2015142566
Radiology2015
Sasieni PD, Smith RA, Duffy SW Informed decision-making and breast cancer screening.. vol.22, (4) 165 - 167.
10.1177/0969141315587344
J Med Screen2015
Seigneurin A, Labarère J, Duffy SW, Colonna M Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods.. vol.39, (6) 1128 - 1135.
10.1016/j.canep.2015.08.013
Cancer Epidemiol2015
Tabar L, Day N, Smith R, Chen THH, Yen AMF, Duffy S Systematic review of the breast cancer screening trials is error-ridden.. vol.108, (11) 430 - 431.
10.1177/0141076815620070
J R Soc Med2015
Pashayan N, Duffy SW, Neal DE, Hamdy FC, Donovan JL, Martin RM, Harrington P, Benlloch S, Amin Al Olama A, Shah M, Kote-Jarai Z, Easton DF, Eeles R, Pharoah PD Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.. vol.17, (10) 789 - 795.
10.1038/gim.2014.192
Genet Med2015
Pashayan N, Pharoah PD, Schleutker J, Talala K, Tammela TL, Määttänen L, Harrington P, Tyrer J, Eeles R, Duffy SW, Auvinen A Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC.. vol.113, (7) 1086 - 1093.
10.1038/bjc.2015.289
Br J Cancer2015
Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: A randomised controlled trial. vol.16, (9) 1123 - 1132.
10.1016/S1470-2045(15)00128-X
The Lancet Oncology2015
Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.. vol.16, (9) 1123 - 1132.
10.1016/S1470-2045(15)00128-X
Lancet Oncol2015
Beckmann K, Duffy SW, Lynch J, Hiller J, Farshid G, Roder D Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.. vol.22, (3) 127 - 135.
10.1177/0969141315573978
J Med Screen2015
Field JK, Devaraj A, Baldwin DR, Duffy S UKLS Impact of Utilization of Risk Assessment in Trial Selection. vol.10, (9) S114 - S115.JOURNAL OF THORACIC ONCOLOGY2015
Hyde R, Davies M, Ledson M, Holemans JA, Page RD, Gosney J, Baldwin DR, Devaraj A, Hansel DM, Duffy SW, FieId JK Exome sequencing of UKLS lung cancer CT screened early stage cancers. vol.75, () .
10.1158/1538-7445.AM2015-4602
CANCER RESEARCH2015
Radon TP, Massat NJ, Jones R, Alrawashdeh W, Dumartin L, Ennis D, Duffy SW, Kocher HM, Pereira SP, Guarner posthumous L, Murta-Nascimento C, Real FX, Malats N, Neoptolemos J, Costello E, Greenhalf W, Lemoine NR, Crnogorac-Jurcevic T Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.. vol.21, (15) 3512 - 3521.
10.1158/1078-0432.CCR-14-2467
Clin Cancer Res2015
Pashayan N, Pharoah PDP, Schleutker J, Talala K, Tammela TLJ, Maattanen L, Harrington P, Tyrer J, Eeles R, Duffy SW, Auvinen A Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish arm of the European randomised study of screening for prostate cancer (ERSPC). vol.75, () .
10.1158/1538-7445.AM2015-4681
CANCER RESEARCH2015
Morrish OWE, Duffy SW, Gilbert FJ Response. vol.276, (2) 618 - 619.
10.1148/radiol.2015150302
Radiology2015
Morrish OWE, Duffy SW, Gilbert FJ Response.. vol.276, (2) 618 - 619.Radiology2015
Massat NJ, Douglas E, Waller J, Wardle J, Duffy SW Variation in cervical and breast cancer screening coverage in England: a cross-sectional analysis to characterise districts with atypical behaviour.. vol.5, (7) e007735.
10.1136/bmjopen-2015-007735
BMJ Open2015
Ali N, Lifford KJ, Carter B, McRonald F, Yadegarfar G, Baldwin DR, Weller D, Hansell DM, Duffy SW, Field JK, Brain K Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.. vol.5, (7) e008254.
10.1136/bmjopen-2015-008254
BMJ Open2015
van der Waal D, Broeders MJM, Verbeek ALM, Duffy SW, Moss SM Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age Trial.. vol.26, (4) 590 - 596.
10.1097/EDE.0000000000000285
Epidemiology2015
Tabár L, Chen H-H, Yen AM-F, Chen SL-S, Fann JC-Y, Chiu SY-H, Smith RA, Duffy SW Response to Miller et al.. vol.21, (4) 459 - 461.
10.1111/tbj.12439
Breast J2015
Geurts SME, Massat NJ, Duffy SW Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths.. vol.113, (1) 142 - 149.
10.1038/bjc.2015.76
Br J Cancer2015
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K, International Agency for Research on Cancer Handbook Working Group Breast-cancer screening--viewpoint of the IARC Working Group.. vol.372, (24) 2353 - 2358.
10.1056/NEJMsr1504363
N Engl J Med2015
Duffy SW, Smith RA A note on the design of cancer screening trials.. vol.22, (2) 65 - 68.
10.1177/0969141315577847
J Med Screen2015
Marcus MW, Chen Y, Raji OY, Duffy SW, Field JK LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence.. vol.8, (6) 570 - 575.
10.1158/1940-6207.CAPR-14-0438
Cancer Prev Res (Phila)2015
Brenner A, Martin J, Wooldrage K, Kralj-Hans I, Pack K, Greliak P, Shah U, Dadswell E, Lucas F, Duffy S, Atkin W RETROSPECTIVE COHORT STUDY TO EXAMINE THE FREQUENCY OF FOLLOW-UP FOR PATIENTS WITH INTERMEDIATE GRADE COLORECTAL ADENOMAS (IA STUDY). vol.64, () A361 - A361.
10.1136/gutjnl-2015-309861.790
GUT2015
Assi V, Massat NJ, Thomas S, MacKay J, Warwick J, Kataoka M, Warsi I, Brentnall A, Warren R, Duffy SW A case-control study to assess the impact of mammographic density on breast cancer risk in women aged 40-49 at intermediate familial risk.. vol.136, (10) 2378 - 2387.
10.1002/ijc.29275
Int J Cancer2015
Beckmann K, Lynch J, Hiller J, Farshid G, Duffy S, Roder D Estimating over-diagnosis of breast cancer (authors' reply).. vol.136, (10) 2487.
10.1002/ijc.29271
Int J Cancer2015
Morrish OWE, Tucker L, Black R, Willsher P, Duffy SW, Gilbert FJ Mammographic breast density: comparison of methods for quantitative evaluation.. vol.275, (2) 356 - 365.
10.1148/radiol.14141508
Radiology2015
Marcus MW, Chen Y, Duffy SW, Field JK Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project.. vol.9, (4) 1902 - 1906.
10.3892/ol.2015.2916
Oncol Lett2015
Beckmann KR, Lynch JW, Hiller JE, Farshid G, Houssami N, Duffy SW, Roder DM A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening.. vol.136, (6) 1411 - 1421.
10.1002/ijc.29124
Int J Cancer2015
Brem RF, Tabár L, Duffy SW, Inciardi MF, Guingrich JA, Hashimoto BE, Lander MR, Lapidus RL, Peterson MK, Rapelyea JA, Roux S, Schilling KJ, Shah BA, Torrente J, Wynn RT, Miller DP Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study.. vol.274, (3) 663 - 673.
10.1148/radiol.14132832
Radiology2015
Zakharova N, Belaya J, Duffy SW, Pyankin S, Pestryakova A The evaluation of the breast cancer screening programme in Western Siberia. vol.24, () S65 - S65.BREAST2015
Brentnall AR, Cuzick J, Field J, Duffy SW A concordance index for matched case-control studies with applications in cancer risk.. vol.34, (3) 396 - 405.
10.1002/sim.6335
Stat Med2015
Beckmann KR, Lynch JW, Hiller JE, Farshid G, Houssami N, Duffy SW, Roder DM A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. vol.136, (6) 1411 - 1421.
10.1002/ijc.29124
International Journal of Cancer2015
Duffy SW Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom. vol.25, (4) 315 - 316.Breast Diseases2015
Tabár L, Yen AM-F, Wu WY-Y, Chen SL-S, Chiu SY-H, Fann JC-Y, Ku MM-S, Smith RA, Duffy SW, Chen TH-H Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs.. vol.21, (1) 13 - 20.
10.1111/tbj.12354
Breast J2015
Tabár L, Chen HH, Yen AMF, Chen SLS, Fann JCY, Chiu SYH, Smith RA, Duffy SW Response to Miller et al.. vol.21, (4) 459 - 461.
10.1111/tbj.12439
Breast Journal2015
Gilbert FJ, Tucker L, Gillan MG, Willsher P, Cooke J, Duncan KA, Michell MJ, Dobson HM, Lim YY, Purushothaman H, Strudley C, Astley SM, Morrish O, Young KC, Duffy SW The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme--a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone.. vol.19, (4) i - 136.
10.3310/hta19040
Health Technol Assess2015
Massat NJ, Sasieni PD, Parmar D, Duffy SW An ongoing case-control study to evaluate the NHS Bowel Cancer Screening Programme.. vol.14, () 945.
10.1186/1471-2407-14-945
BMC Cancer2014
Offman J, Myles J, Ariyanayagam S, Colorado Z, Sharp M, Cruice M, North BV, Shiel S, Baker T, Jefferies R, Binysh K, Duffy SW A telephone reminder intervention to improve breast screening information and access.. vol.128, (11) 1017 - 1022.
10.1016/j.puhe.2014.09.007
Public Health2014
Warwick J, Birke H, Stone J, Warren RML, Pinney E, Brentnall AR, Duffy SW, Howell A, Cuzick J Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I.. vol.16, (5) 451.
10.1186/s13058-014-0451-5
Breast Cancer Res2014
Evans DG, Kesavan N, Lim Y, Gadde S, Hurley E, Massat NJ, Maxwell AJ, Ingham S, Eeles R, Leach MO, MARIBS Group , Howell A, Duffy SW Erratum to: MRI breast screening in high-risk women: cancer detection and survival analysis.. vol.147, (3) 691.
10.1007/s10549-014-3106-4
Breast Cancer Res Treat2014
Pashayan N, Duffy SW, Neal DE, Hamdy F, Donovan J, Martin RM, Harrington P, Benlloch S, Al Olama AA, Shah M, Kote-Jarai Z, Easton DF, Eeles R, Pharoah PD Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. vol.74, (19) .
10.1158/1538-7445.AM2014-261
CANCER RESEARCH2014
Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM, Harvie MN Risk determination and prevention of breast cancer.. vol.16, (5) 446.
10.1186/s13058-014-0446-2
Breast Cancer Res2014
Shankleman J, Massat NJ, Khagram L, Ariyanayagam S, Garner A, Khatoon S, Rainbow S, Rangrez S, Colorado Z, Hu W, Parmar D, Duffy SW Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas.. vol.111, (7) 1440 - 1447.
10.1038/bjc.2014.363
Br J Cancer2014
Morgan DAL, Bates T, Duffy SW, Pinder SE Addendum to BASOII Trial report. vol.50, (14) 2517 - 2518.
10.1016/j.ejca.2014.05.023
European Journal of Cancer2014
Morgan DAL, Bates T, Duffy SW, Pinder SE Addendum to BASOII Trial report.. vol.50, (14) 2517 - 2518.
10.1016/j.ejca.2014.05.023
Eur J Cancer2014
Massat NJ, Tataru D, Parmar D, Sasieni PD, Duffy SW CASE FATALITY IN BREAST CANCER: RELATIVE EFFECT OF ATTENDANCE AT BREAST SCREENING AND CANCER TREATMENT. vol.25, () .
10.1093/annonc/mdu438.52
ANNALS OF ONCOLOGY2014
Brains KE, Lifford K, Carter B, McRonald F, Yadegarfar G, Baldwin D, Weller D, Hansell DM, Duffy SW, Field JK IMPACT OF LUNG CANCER SCREENING IN A HIGH-RISK POPULATION: THE UK LUNG SCREENING (UKLS) TRIAL. vol.21, () S81 - S81.INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE2014
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR, Haider S, Brouilette K, Saha A, Vallath S, Bowen R, Chelala C, Eccles D, Tapper WJ, Thompson AM, Quinlan P, Jordan L, Gillett C Therapeutic targeting of integrin αvβ6 in breast cancer.. vol.106, (8) .
10.1093/jnci/dju169
J Natl Cancer Inst2014
Paci E, Broeders M, Hofvind S, Puliti D, Duffy SW, EUROSCREEN Working Group European breast cancer service screening outcomes: a first balance sheet of the benefits and harms.. vol.23, (7) 1159 - 1163.
10.1158/1055-9965.EPI-13-0320
Cancer Epidemiol Biomarkers Prev2014
Marcus MW, Raji OY, Chen Y, Duffy SW, Field JK Factors associated with dropout in a lung cancer high‑risk cohort--the Liverpool lung project.. vol.44, (6) 2146 - 2152.
10.3892/ijo.2014.2371
Int J Oncol2014
Evans DG, Kesavan N, Lim Y, Gadde S, Hurley E, Massat NJ, Maxwell AJ, Ingham S, Eeles R, Leach MO, MARIBS Group , Howell A, Duffy SW MRI breast screening in high-risk women: cancer detection and survival analysis.. vol.145, (3) 663 - 672.
10.1007/s10549-014-2931-9
Breast Cancer Res Treat2014
Duffy SW Recent results from the two Canadian breast screening trials.. vol.21, (2) 59 - 60.
10.1177/0969141314537615
J Med Screen2014
Chen Y, Marcus MW, Niaz A, Duffy SW, Field JK MyLungRisk: A user-friendly, web-based calculator for risk assessment of lung cancer based on the validated Liverpool Lung Project risk prediction model. vol.52, (3) 144 - 152.
10.1080/14635240.2014.888814
International Journal of Health Promotion and Education2014
Duffy SW, Field JK, Allgood PC, Seigneurin A Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom.. vol.110, (7) 1834 - 1840.
10.1038/bjc.2014.63
Br J Cancer2014
Seigneurin A, Field JK, Gachet A, Duffy SW A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer.. vol.25, (4) 781 - 791.
10.1093/annonc/mdt491
Ann Oncol2014
Duffy SW, Field JK, Allgood PC, Seigneurin A Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. vol.110, (7) 1834 - 1840.
10.1038/bjc.2014.63
British Journal of Cancer2014
Baldwin DR, Hansell DM, Duffy SW, Field JK Lung cancer screening with low dose computed tomography. vol.348, () .
10.1136/bmj.g1970
BMJ-BRITISH MEDICAL JOURNAL2014
Baldwin DR, Hansell DM, Duffy SW, Field JK Lung cancer screening with low dose computed tomography.. vol.348, () g1970.
10.1136/bmj.g1970
BMJ2014
Duffy SW Breast cancer screening causes more harm than good: No.. vol.6, (1) 81 - 82.J Prim Health Care2014
Poum A, Promthet S, Duffy SW, Parkin DM Factors Associated With Delayed Diagnosis of Breast Cancer in Northeast Thailand. vol.24, (2) 102 - 108.
10.2188/jea.JE20130090
JOURNAL OF EPIDEMIOLOGY2014
Evans DG, Thomas S, Caunt J, Roberts L, Howell A, Wilson M, Fox R, Sibbering DM, Moss S, Wallis MG, Eccles DM, Duffy S, Grp FS Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02). vol.13, (1) 13 - 21.
10.1007/s10689-013-9661-8
FAMILIAL CANCER2014
van der Waal D, Broeders MJM, Verbeek ALM, Duffy SW, Moss SM The case-control design and breast cancer screening effectiveness: Insights from the UK Age trial. vol.50, () S74 - S74.EUROPEAN JOURNAL OF CANCER2014
Duffy SW, Michalopoulos D, Sebuødegård S, Hofvind S Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.. vol.21, (1) 24 - 29.
10.1177/0969141313517676
J Med Screen2014
Dibden A, Offman J, Parmar D, Jenkins J, Slater J, Binysh K, McSorley J, Scorfield S, Cumming P, Liao X-H, Ryan M, Harker D, Stevens G, Rogers N, Blanks R, Sellars S, Patnick J, Duffy SW Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme.. vol.110, (3) 560 - 564.
10.1038/bjc.2013.778
Br J Cancer2014
Field JK, Aberle DR, Altorki N, Baldwin DR, Dresler C, Duffy SW, Goldstraw P, Hirsch FR, Pedersen JH, de Koning HJ, Mulshine JL, Sullivan DC, Tsao M-S, Travis WD, International Association for the Study of Lung Cancer Strategic Screening Advisory Committee The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations.. vol.9, (2) 141 - 143.
10.1097/JTO.0000000000000060
J Thorac Oncol2014
Offman J, Myles J, Ariyanayagam S, Colorado Z, Sharp M, Cruice M, North BV, Shiel S, Baker T, Jefferies R, Binysh K, Duffy SW A telephone reminder intervention to improve breast screening information and access. vol.128, (11) 1017 - 1022.
10.1016/j.puhe.2014.09.007
Public Health2014
Duffy SW Authors' reply.. vol.16, (3) 404.
10.1186/bcr3671
Breast Cancer Res2014
Zakharova N, Duffy S Early impact of mammographic screening in Western Siberia. vol.20, (2) 219 - 220.
10.1111/tbj.12248
Breast Journal2014
Shankleman J, Massat NJ, Khagram L, Ariyanayagam S, Garner A, Khatoon S, Rainbow S, Rangrez S, Colorado Z, Hu W, Parmar D, Duffy SW Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas.. vol.111, (7) 1440 - 1447.
10.1038/bjc.2014.363
British journal of cancer2014
Marcus MW, Raji OY, Chen Y, Duffy SW, Field JK Factors associated with dropout in a lung cancer high-risk cohort - The Liverpool lung project. vol.45, (6) 2146 - 2152.
10.3892/ijo.2014.2371
International Journal of Oncology2014
McRonald FE, Yadegarfar G, Baldwin DR, Devaraj A, Brain KE, Eisen T, Holemans JA, Ledson M, Screaton N, Rintoul RC, Hands CJ, Lifford K, Whynes D, Kerr KM, Page R, Parmar M, Wald N, Weller D, Williamson PR, Myles J The UK Lung Screen (UKLS): Demographic profile of first 88,897 approaches provides recommendations for population screening. vol.7, (3) 362 - 371.
10.1158/1940-6207.CAPR-13-0206
Cancer Prevention Research2014
Tabár L, Dean PB, Chen THH, Yen AMF, Chiu SYH, Tot T, Smith RA, Duffy SW The impact of mammography screening on the diagnosis and management of early-phase breast cancer. vol., () 31 - 78.
10.1007/978-1-4614-8063-1_2
2014
Field JK, Devaraj A, Baldwin DR, Holemans J, Screaton N, Ledson M, Rintoul RC, Nair A, Gosney JR, Rassl DM, Kerr KM, Duffy S, Hansell DM UK Lung Cancer Screening trial (UKLS): Prevalence data at baseline. vol.83, () S24 - S25.LUNG CANCER2014
Smith RA, Duffy S, Chen TH-H, Yen AMF, Tabar L Disparities in the estimates of benefits and harms from mammography: Are the numbers really different?. vol.73, () .
10.1158/0008-5472.SABCS13-S1-10
CANCER RESEARCH2013
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR, Haider S, Brouilette K, Saha A, Vallath S, Bowen R, Chelala C, Eccles DM, Tapper WJ, Thompson AM, Quinlan P, Jordan LB, Gillet C Integrin avb6 is a therapeutic target for high-risk breast cancer and enhances trastuzumab efficacy. vol.73, () .
10.1158/0008-5472.SABCS13-P4-15-01
CANCER RESEARCH2013
Smith RA, Wu WY-Y, Tabar L, Chen SL-S, Yen AM-F, Duffy SW, Tot T, Chiu SY-H, Fann JC-Y, Chen TH-H The contribution of mammographic appearance, basal-like phenotype, and disease extent to prediction of breast cancer death. vol.73, () .
10.1158/0008-5472.SABCS13-P4-03-07
CANCER RESEARCH2013
Massat NJ, Sasieni PD, Parmar D, Duffy SW An ongoing case-control study to evaluate the NHS breast screening programme.. vol.13, () 596.
10.1186/1471-2407-13-596
BMC Cancer2013
Field JK, Hansell DM, Duffy SW, Baldwin DR CT screening for lung cancer: countdown to implementation. vol.14, (13) E591 - E600.
10.1016/S1470-2045(13)70293-6
LANCET ONCOLOGY2013
Field JK, Devaraj A, Baldwin DR, Holemans J, Screaton N, Ledson M, Rintoul RC, Nair A, Gosney JR, Rassl D, Kerr KM, Duffy S, Hansell DH UK LUNG CANCER SCREENING TRIAL (UKLS): BASE LINE DATA. vol.8, () S685 - S685.JOURNAL OF THORACIC ONCOLOGY2013
Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, Bundred NJ, Burchell JM, Campbell AM, Carroll JS, Clarke RB, Coles CE, Cook GJR, Cox A, Curtin NJ, Dekker LV Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. vol.15, (5) .
10.1186/bcr3493
Breast Cancer Research2013
Field JK, Chen Y, Marcus MW, McRonald FE, Raji OY, Duffy SW The contribution of risk prediction models to early detection of lung cancer. vol.108, (5) 304 - 311.
10.1002/jso.23384
Journal of Surgical Oncology2013
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR, Haider S, Brouilette K, Saha A, Vallath S, Bowen R, Chelala C, Eccles D, Tapper WJ, Thompson AM, Quinlan P, Jordan L, Gillett C Therapeutic targeting of integrin alpha v beta 6 in high-risk breast cancer. vol.11, () .
10.1158/1557-3125.ADVBC-B046
MOLECULAR CANCER RESEARCH2013
Paci E, Smith R, Broeders M, Duffy S Complex statistical techniques cannot overcome weak methodology in the evaluation of breast cancer mortality trends. vol.106, (9) 346 - 346.
10.1177/0141076813501807
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE2013
Zakharova N, Duffy S, Pyankin S, Pestryakova A Regional experience of the mammographic screening implementation in Western Siberia. vol.49, () S323 - S323.EUROPEAN JOURNAL OF CANCER2013
Field JK, Oudkerk M, Pedersen JH, Duffy SW Prospects for population screening and diagnosis of lung cancer. vol.382, (9893) 732 - 741.
10.1016/S0140-6736(13)61614-1
The Lancet2013
Offman J, Wilson M, Lamont M, Birke H, Kutt E, Marriage S, Loughrey Y, Hudson S, Hartley A, Smith J, Eckersley B, Dungey F, Parmar D, Patnick J, Duffy SW A randomised trial of weekend and evening breast screening appointments.. vol.109, (3) 597 - 602.
10.1038/bjc.2013.377
Br J Cancer2013
Klevesath MB, Pantel K, Agbaje O, Provenzano E, Wishart GC, Gough P, Pinder SE, Duffy S, Purushotham AD Patterns of metastatic spread in early breast cancer. vol.22, (4) 449 - 454.
10.1016/j.breast.2013.04.017
Breast2013
Blamey RW, Bates T, Chetty U, Duffy SW, Ellis IO, George D, Mallon E, Mitchell MJ, Monypenny I, Morgan DAL, Macmillan RD, Patnick J, Pinder SE, Oncology BASOBAS Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. vol.49, (10) 2294 - 2302.
10.1016/j.ejca.2013.02.031
EUROPEAN JOURNAL OF CANCER2013
Duffy SW, Parmar D Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time.. vol.15, (3) R41.
10.1186/bcr3427
Breast Cancer Res2013
Field JK, Baldwin D, Devaraj A, Brain K, Eisen T, Holemans J, Ledson M, Screaton N, Rintoul RC, Yadegarfar G, Hands C, McRonald FE, Lifford K, Whynes D, Kerr K, Page R, Parmar M, Weller D, Whynes D, Williamson P United Kingdom lung cancer screening trial (UKLS): First 88897 approaches.. vol.73, (8) .
10.1158/1538-7445.AM2013-3631
CANCER RESEARCH2013
Field JK, Raji OY, Duffy SW Predictive Accuracy of the Liverpool Lung Project Risk Model RESPONSE. vol.158, (7) 568 - 569.
10.7326/0003-4819-158-7-201304020-00015
ANNALS OF INTERNAL MEDICINE2013
Field JK, Raji OY, Duffy SW RE: Predictive accuracy of the Liverpool lung project risk model. vol.158, (7) 568 - 569.Annals of Internal Medicine2013
Duffy SW The benefits and harms of breast cancer screening. vol.381, (9869) 802 - 802.
10.1016/S0140-6736(13)60624-8
LANCET2013
Duffy SW, Mackay J, Thomas S, Anderson E, Chen TH, Ellis I, Evans G, Fielder H, Fox R, Gui G, Macmillan D, Moss S, Rogers C, Sibbering M, Wallis M, Warren R, Watson E, Whynes D, Allgood P, Caunt J Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.. vol.17, (11) vii - 95.
10.3310/hta17110
Health Technol Assess2013
Duffy SW In Reply: The benefits and harms of breast cancer screening. vol.381, (9869) 802.The Lancet2013
Nagtegaal ID, Duffy SW Reduction in rate of node metastases with breast screening: consistency of association with tumor size. vol.137, (3) 653 - 663.
10.1007/s10549-012-2384-y
BREAST CANCER RESEARCH AND TREATMENT2013
Field JK, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K, Page R, Parmar M, Weller D, Whynes D, Williamson P Authors' response. vol.68, (1) 105 - 105.
10.1136/thoraxjnl-2012-202442
THORAX2013
Paci E, Broeders M, Hofvind S, Duffy SW In Reply: The benefits and harms of breast cancer screening. vol.381, (9869) 800 - 801.The Lancet2013
Klevesath MB, Pantel K, Agbaje O, Provenzano E, Wishart GC, Gough P, Pinder SE, Duffy S, Purushotham AD Patterns of metastatic spread in early breast cancer. vol., () .
10.1016/j.breast.2013.04.017
Breast2013
Massat NJ, Moss SM, Halloran SP, Duffy SW Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.. vol.20, (3) 125 - 148.
10.1177/0969141313501292
J Med Screen2013
Field JK, Chen Y, Marcus MW, Mcronald FE, Raji OY, Duffy SW The contribution of risk prediction models to early detection of lung cancer. vol., () .
10.1002/jso.23384
Journal of Surgical Oncology2013
McRonald F, Baldwin DR, Devaraj A, Brain K, Eisen T, Holeman J, Ledson M, Screaton N, Rintoul RC, Yadegarfar G, Hands C, Lifford K, Whynes D, Kerr KM, Page R, Parmar M, Weller D, Williamson P, Hansell D, Duffy SW The uniqueness of the United Kingdom Lung Cancer Screening trial (UKLS) - a population screening study. vol.79, () S28 - S29.LUNG CANCER2013
Warwick J, Will O, Allgood P, Miller R, Duffy S, Greenberg D Variation in colorectal cancer treatment and survival: a cohort study covering the East Anglia region.. vol.15, (10) 1243 - 1252.
10.1111/codi.12308
Colorectal Dis2013
Yen AM-F, Duffy SW, Chen TH-H, Chen L-S, Chiu SY-H, Fann JC-Y, Wu WY-Y, Su C-W, Smith RA, Tabar L Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. vol.118, (23) 5728 - 5732.
10.1002/cncr.27580
CANCER2012
Gao F, Machin D, Chow K-Y, Sim Y-F, Duffy SW, Matchar DB, Goh C-H, Chia K-S Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study). vol.12, () .
10.1186/1471-2407-12-529
BMC CANCER2012
Beral V, Bull D, Pirie K, Reeves G, Peto R, Skegg D, LaVecchia C, Magnusson C, Pike MC, Thomas D, Hamajima N, Hirose K, Tajima K, Rohan T, Friedenreich CM, Calle EE, Gapstur SM, Patel AV, Coates RJ, Liff JM Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. vol.13, (11) 1141 - 1151.
10.1016/S1470-2045(12)70425-4
LANCET ONCOLOGY2012
Zakharova NA, Duffy SW, Mackay J, Kotlyarov EV, Filimonov AV, Barinov K, Gromut I, Belan EV FIVE-YEAR RESULTS OF THE BREAST CANCER SCREENING PROGRAMME IN UGRA. vol.23, () 470 - 470.ANNALS OF ONCOLOGY2012
Raji OY, Duffy SW, Agbaje OF, Baker SG, Christiani DC, Cassidy A, Field JK Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer A Case-Control and Cohort Validation Study. vol.157, (4) 242 - +.
10.7326/0003-4819-157-4-201208210-00004
ANNALS OF INTERNAL MEDICINE2012
Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit. vol.131, (2) 417 - 425.
10.1002/ijc.26394
INTERNATIONAL JOURNAL OF CANCER2012
Field J, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K, Page R, Parmar M, Weller D, Whynes D, Williamson P Tuberculosis through the rose tinted spectacles of the EBUS endoscopist: be aware of the bias response. vol.67, (7) 650 - 650.
10.1136/thoraxjnl-2011-200822
THORAX2012
Tabár L, Smith RA, Chen THH, Duffy SW Response. vol.263, (1) 308.
10.1148/radiol.11111988
Radiology2012
Smith RA, Duffy SW, Tabar L Breast Cancer Screening: The Evolving Evidence. vol.26, (5) 471 - 486.ONCOLOGY-NEW YORK2012
Smith RA, Duffy SW, Tabár L Breast cancer screening: the evolving evidence.. vol.26, (5) .Oncology (Williston Park, N.Y.)2012
Britton P, Warwick J, Wallis MG, O'Keeffe S, Taylor K, Sinnatamby R, Barter S, Gaskarth M, Duffy SW, Wishart GC Measuring the accuracy of diagnostic imaging in symptomatic breast patients: team and individual performance. vol.85, (1012) 415 - 422.
10.1259/bjr/32906819
BRITISH JOURNAL OF RADIOLOGY2012
Tabar L, Smith RA, Chen THH, Duffy SW Swedish Two-County Trial: Total Mortality Data Are Needed Response. vol.263, (1) 308 - 308.RADIOLOGY2012
Tabár L, Dean PB, Tony Chen HH, Duffy SW, Yen AMF, Chiu SYH Breast Imaging: Mammography. vol., () .2012
Pinker-Domenig K, Bogner W, Gruber S, Bickel H, Duffy S, Schernthaner M, Dubsky P, Pluschnig U, Rudas M, Trattnig S, Helbich TH High resolution MRI of the breast at 3 T: which BI-RADSA (R) descriptors are most strongly associated with the diagnosis of breast cancer?. vol.22, (2) 322 - 330.
10.1007/s00330-011-2256-6
EUROPEAN RADIOLOGY2012
Duffy S Misplaced criticism of breast screening research.. vol.105, (2) 53 - 54.
10.1258/jrsm.2011.110311
J R Soc Med2012
Tabár L, Smith RA, Chen THH, Duffy SW Response. vol.262, (2) 730 - 731.
10.1148/radiol.11111756
Radiology2012
Tabar L, Smith RA, Chen TH-H, Duffy SW The Two-County Breast Screening Trial Cannot Provide a Reliable Estimate of the Effect of Breast Cancer Screening Response. vol.262, (2) 730 - 731.RADIOLOGY2012
Field J, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K, Page R, Parmar M, Weller D, Whynes D, Williamson P Authors' response. vol.67, (7) 650.
10.1136/thoraxjnl-2011-200822
Thorax2012
Hamajima N, Hirose K, Tajima K, Rohan T, Friedenreich CM, Calle EE, Gapstur SM, Patel AV, Coates RJ, Liff JM, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Marcou Y, Kakouri E, Duffy SW, Morabia A, Schuman L, Stewart W Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. vol.13, (11) 1141 - 1151.
10.1016/S1470-2045(12)70425-4
The Lancet Oncology2012
Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E, Grp EUROSCREENW Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. vol.19, () 42 - 56.
10.1258/jms.2012.012082
JOURNAL OF MEDICAL SCREENING2012
Hellquist BN, Duffy SW, Nystrom L, Jonsson H Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden. vol.19, (1) 14 - 19.
10.1258/jms.2012.011104
JOURNAL OF MEDICAL SCREENING2012
Cheol Kim D, Thorat MA, Lee MR, Cho SH, Vasiljevi¿ N, Scibior-Bentkowska D, Wu K, Ahmad AS, Duffy S, Cuzick JM, Lorincz AT Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes.. vol.11, (2-3) 75 - 88.
10.3233/CBM-2012-0266
Cancer Biomark2012
Duffy S, Williams D, Stevens T, Kegel I, Jansen J, Cesar P, Healey PGT Remote Music Tuition. vol., () 333 - 338.Proceedings of 9th Sound and Music Computing Conference2012
Brentnall AR, Duffy SW, Baio G, Raine R Strategy for power calculation for interactions: application to a trial of interventions to improve uptake of bowel cancer screening.. vol.33, (1) 213 - 217.
10.1016/j.cct.2011.09.021
Contemp Clin Trials2012
Ancelle-Park R, Armaroli P, Ascunce N, Bisanti L, Bellisario C, Broeders M, Cogo C, de Koning H, Duffy SW, Frigerio A, Giordano L, Hofvind S, Jonsson H, Lynge E, Massat N, Miccinesi G, Moss S, Naldoni C, Njor S, Nystrom L Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. vol.19, () 5 - 13.
10.1258/jms.2012.012077
JOURNAL OF MEDICAL SCREENING2012
Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E, EUROSCREEN Working Group The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies.. vol.19 Suppl 1, () 14 - 25.
10.1258/jms.2012.012078
J Med Screen2012
Smith RA, Duffy SW Overdiagnosis in Breast Cancer Screening: Methodological Considerations of Current Estimates.. vol.71, () .
10.1158/0008-5472.SABCS11-S4-1
CANCER RESEARCH2011
Assi V, Warwick J, Cuzick J, Duffy SW Clinical and epidemiological issues in mammographic density.. vol.9, (1) 33 - 40.
10.1038/nrclinonc.2011.173
Nat Rev Clin Oncol2011
Brentnall AR, Duffy SW, Crowder MJ, Gillan MGC, Astley SM, Wallis MG, James J, Boggis CRM, Gilbert FJ A METHOD FOR EXPLORATORY REPEATED-MEASURES ANALYSIS APPLIED TO A BREAST-CANCER SCREENING STUDY. vol.5, (4) 2448 - 2469.
10.1214/11-AOAS481
ANNALS OF APPLIED STATISTICS2011
Chen M-K, Hung H-F, Duffy S, Yen AM-F, Chen H-H Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.. vol.17, (6) 1050 - 1058.
10.1111/j.1365-2753.2010.01453.x
J Eval Clin Pract2011
Duffy S A community creating their own rules on foursquare. vol., () 7 - 12.
10.1109/MOSN.2011.6060786
Proceedings - 2011 Workshop on Mobile and Online Social Networks, MOSN 20112011
Jonsson H, Holmstrom B, Duffy SW, Stattin P Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden. vol.129, (8) 1881 - 1888.
10.1002/ijc.25846
INT J CANCER2011
Zakharova N, Duffy SW, Mackay J, Kotlyarov E, Filimonov A, Belousov V Current Results of the Breast Cancer Screening Programme After Four Years Implementation in Khanty-Mansiysky Autonomous Okrug - Ugra. vol.47, () S258 - S258.EUROPEAN JOURNAL OF CANCER2011
Kopans DB, Smith RA, Duffy SW Mammographic Screening and "Overdiagnosis". vol.260, (3) 616 - 620.
10.1148/radiol.11110716
RADIOLOGY2011
Tabar L, Vitak B, Chen THH, Yen AMF, Cohen A, Tot T, Chiu SYH, Chen SLS, Fann JCY, Rosell J, Fohlin H, Smith RA, Duffy SW Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades. vol.260, (3) 658 - 663.
10.1148/radiol.11110469
RADIOLOGY2011
Field JK, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K, Page R, Parmar M, Weller D, Williamson P, Whynes D, UKLS Team CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. vol.66, (8) 736 - 737.
10.1136/thoraxjnl-2011-200351
THORAX2011
Field JK, Raji OY, Cassidy A, Mimnagh C, Hughes J, Warburton C, Giles T, Liloglou T, Gosney J, Calverley P, Duffy SW, Page R, Ashton M A PILOT LUNG CANCER EARLY DETECTION STUDY IN A PRIMARY CARE PRACTICE IN KNOWSLEY, MERSEYSIDE: THE LIVERPOOL LUNG PROJECT PRIMARY CARE IMPLEMENTATION PROGRAMME (LLP-PCIP). vol.6, (6) S1393 - S1393.J THORAC ONCOL2011
Uhry Z, Hedelin G, Colonna M, Asselain B, Arveux P, Exbrayat C, Guldenfelds C, Soler-Michel P, Molinie F, Tretarre B, Rogel A, Courtial I, Danzon A, Guizard AV, Ancelle-Park R, Eilstein D, Duffy S Modelling the effect of breast cancer screening on related mortality using French data. vol.35, (3) 235 - 242.
10.1016/j.canep.2010.10.009
CANCER EPIDEMIOL2011
Uhry Z, Hedelin G, Colonna M, Duffy S Reply to: Lost opportunity to usefully examine French breast cancer screening mortality. vol.35, (3) 307 - 308.
10.1016/j.canep.2011.02.007
CANCER EPIDEMIOL2011
Field JK, Duffy S, Baldwin D, Brain K, Eisen T, Hands CJD, Kerr KM, Page R, Parmar M, Wald N, Weller D, Whynes D, Williamson P, Hansell D UNITED KINGDOM LUNG CANCER SCREENING (UKLS) TRIAL. vol.6, (6) S1382 - S1383.J THORAC ONCOL2011
Allgood PC, Duffy SW, Kearins O, O'Sullivan E, Tappenden N, Wallis MG, Lawrence G Explaining the difference in prognosis between screen-detected and symptomatic breast cancers.. vol.104, (11) 1680 - 1685.
10.1038/bjc.2011.144
Br J Cancer2011
Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, Easton DF, Eeles R, Pharoah P Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. vol.104, (10) 1656 - 1663.
10.1038/bjc.2011.118
BRIT J CANCER2011
Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RML Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.. vol.103, (9) 744 - 752.
10.1093/jnci/djr079
J Natl Cancer Inst2011
Nagtegaal ID, Allgood PC, Duffy SW, Kearins O, Sullivan EO, Tappenden N, Wallis M, Lawrence G Prognosis and pathology of screen-detected carcinomas: how different are they?. vol.117, (7) 1360 - 1368.
10.1002/cncr.25613
Cancer2011
Perry NM, Patani N, Milner SE, Pinker K, Mokbel K, Allgood PC, Duffy SW The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit.. vol.21, (4) 676 - 682.
10.1007/s00330-010-1968-3
Eur Radiol2011
Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer.. vol.66, (4) 308 - 313.
10.1136/thx.2010.152066
Thorax2011
Pashayan N, Pharoah P, Tabar L, Neal DE, Martin RM, Donovan J, Hamdy F, Duffy SW Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence. vol.35, (2) 139 - 144.
10.1016/j.canep.2010.07.012
CANCER EPIDEMIOL2011
Pashayan N, Pharoah P, Neal DE, Hamdy F, Donovan J, Martin RM, Greenberg D, Duffy SW PSA-detected prostate cancer and the potential for dedifferentiation-estimating the proportion capable of progression. vol.128, (6) 1462 - 1470.
10.1002/ijc.25471
INT J CANCER2011
Duffy SW, Mackay J Elementary flaws in the FH01 study Reply. vol.12, (3) 215 - 216.
10.1016/S1470-2045(11)70048-1
LANCET ONCOL2011
Wong CS, Lim GH, Gao F, Jakes RW, Offman J, Chia KS, Duffy SW Mammographic density and its interaction with other breast cancer risk factors in an Asian population. vol.104, (5) 871 - 874.
10.1038/sj.bjc.6606085
BRIT J CANCER2011
Hellquist BN, Duffy SW, Abdsaleh S, Bjorneld L, Bordas P, Tabar L, Vitak B, Zackrisson S, Nystrom L, Jonsson H Effectiveness of Population-Based Service Screening With Mammography for Women Ages 40 to 49 Years Evaluation of the Swedish Mammography Screening in Young Women (SCRY) Cohort. vol.117, (4) 714 - 722.
10.1002/cncr.25650
CANCER-AM CANCER SOC2011
Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, Viták B, Zackrisson S, Nyström L, Jonsson H Effectiveness of population-based service screening with mammography for women ages 40 to 49 years. vol.117, (4) 714 - 722.
10.1002/cncr.25650
Cancer2011
Zakharova N, Duffy SW, Mackay J, Kotlyarov E The introduction of a breast cancer screening programme in a region with a population at medium risk for developing breast cancer: Khanty-Mansiysky autonomous Okrug - Ugra (Russian Federation). vol.5, (1) .
10.3332/ecancer.2011.195
ecancermedicalscience2011
Duffy SW, Smith RA More on screening mammography.. vol.364, (3) 283.
10.1056/NEJMc1011881#SA3
N Engl J Med2011
Clark SE, Warwick J, Carpenter R, Bowen RL, Duffy SW, Jones JL Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.. vol.104, (1) 120 - 127.
10.1038/sj.bjc.6606021
Br J Cancer2011
Duffy SW, Treasure FP Potential surrogate endpoints in cancer research--some considerations and examples.. vol.10, (1) 34 - 39.
10.1002/pst.406
Pharm Stat2011
Gilbert FJ, Gillan MGC, Michell MJ, Young KC, Dobson HM, Cooke J, Purushothaman H, Lim YY, Astley SM, Duffy SW TOMMY Trial (a comparison of tomosynthesis with digital mammography in the UK NHS breast screening programme) setting up a multicentre imaging trial. vol.13, () .BREAST CANCER RESEARCH2011
Beral V, Alexander M, Duffy S, Ellis IO, Given-Wilson R, Holmberg L, Moss SM, Ramirez A, Reed MWR, Rubin C, Whelehan P, Wilson R, Young KC The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer. vol.18, (4) 210 - 212.
10.1258/jms.2011.011134
JOURNAL OF MEDICAL SCREENING2011
Chang J-C, Chen TH-H, Duffy SW, Yen AM-F, Chen SL-S Decision modelling of economic evaluation of intervention programme of breast cancer.. vol.16, (6) 1282 - 1288.
10.1111/j.1365-2753.2009.01329.x
J Eval Clin Pract2010
Duffy SW, Mackay J, Thomas S, Anderson E, Evans DG, Fielder H, Fox R, Gray J, Gui G, Macmillan D, Moss S, Rogers C, Sainsbury R, Sibbering M, Boggis C, Burn J, Cuzick J, Haward B, Howell A, Mansel R Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. vol.11, (12) 1127 - 1134.
10.1016/S1470-2045(10)70263-1
LANCET ONCOL2010
Raji OY, Duffy SW, Xinarianos G, Liloglou T, Young RP, Field JK Representing Epistasis Effects of Susceptibility SNPs in a Risk Prediction Model for Lung Cancer. vol.34, (8) 979 - 980.GENETIC EPIDEMIOLOGY2010
Nagtegaal ID, Allgood PC, Duffy SW, Kearins O, Sullivan EO, Tappenden N, Wallis M, Lawrence G Prognosis and pathology of screen-detected carcinomas: how different are they?. vol., () .
10.1002/cncr.25613
Cancer2010
Stone J, Ding J, Warren RML, Duffy SW Predicting breast cancer risk using mammographic density measurements from both mammogram sides and views. vol.124, (2) 551 - 554.
10.1007/s10549-010-0976-y
BREAST CANCER RES TR2010
Chen LS, Yen AMF, Duffy SW, Tabar L, Lin WC, Chen HH Computer-aided System of Evaluation for Population-based All-in-One Service Screening (CASE-PASS): From Study Design to Outcome Analysis with Bias Adjustment. vol.20, (10) 786 - 796.
10.1016/j.annepidem.2010.06.003
ANN EPIDEMIOL2010
Yen AMF, Chen THH, Duffy SW, Chen CD Incorporating frailty in a multi-state model: application to disease natural history modelling of adenoma-carcinoma in the large bowel. vol.19, (5) 529 - 546.
10.1177/0962280209359862
STAT METHODS MED RES2010
Duffy SW, Sasieni P, Olsen AH, Cafferty FH Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme.. vol.19, (5) 547 - 555.
10.1177/0962280209358140
Stat Methods Med Res2010
Uhry Z, Hedelin G, Colonna M, Asselain B, Arveux P, Rogel A, Exbrayat C, Guldenfels C, Courtial I, Soler-Michel P, Molinie F, Eilstein D, Duffy SW Multi-state Markov models in cancer screening evaluation: a brief review and case study. vol.19, (5) 463 - 486.
10.1177/0962280209359848
STAT METHODS MED RES2010
Zakharova NA, Duffy SW, Mackay J, Kotlyarov EV THE EVALUATION OF THE BREAST CANCER SCREENING PROGRAMME IN THE KHANTY-MANSIYSKY AUTONOMOUS OKRUG - UGRA, WESTERN SIBERIA. vol.21, () 349 - 349.ANNALS OF ONCOLOGY2010
Atkin W, Wardle J, Kralj-Hans I, Duffy S Flexible sigmoidoscopy to prevent colorectal cancer Reply. vol.376, (9744) 871 - 872.
10.1016/S0140-6736(10)61408-0
LANCET2010
Atkin W, Kralj-Hans I, Wardle J, Duffy S Colorectal cancer screening: Randomised trials of flexible sigmoidoscopy. vol.341, (7770) .
10.1136/bmj.c4618
BMJ (Online)2010
Atkin W, Kralj-Hans I, Wardle J, Duffy S Colorectal cancer screening Randomised trials of flexible sigmoidoscopy. vol.341, () .
10.1136/bmj.c4618
BRITISH MEDICAL JOURNAL2010
James JJ, Gilbert FJ, Wallis MG, Gillan MGC, Astley SM, Boggis CRM, Agbaje OF, Brentnall AR, DUFFY SW Mammographic Features of Breast Cancers at Single Reading with Computer-aided Detection and at Double Reading in a Large Multicenter Prospective Trial of Computer-aided Detection: CADET II. vol.256, (2) 379 - 386.
10.1148/radiol.10091899
Radiology2010
Wishart GC, Warwick J, Pitsinis V, Duffy S, Britton PD Measuring performance in clinical breast examination. vol.97, (8) 1246 - 1252.
10.1002/bjs.7108
BRIT J SURG2010
D'Amelio AM, Cassidy A, Asomaning K, Raji OY, Duffy SW, Field JK, Spitz MR, Christiani D, Etzel CJ Comparison of discriminatory power and accuracy of three lung cancer risk models. vol.103, (3) 423 - 429.
10.1038/sj.bjc.6605759
BRIT J CANCER2010
Wessler JD, Pashayan N, Greenberg DC, Duffy SW Age-period-cohort analysis of colorectal cancer in East Anglia, 1971-2005. vol.34, (3) 232 - 237.
10.1016/j.canep.2010.03.012
CANCER EPIDEMIOL2010
Duffy SW, Tabar L, Olsen AH Erratum: Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England (Journal of Medical Screening (2010) 17 (25-30)). vol.17, (2) 106.
10.1258/jms.2010.010350
Journal of Medical Screening2010
Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JMA, Parkin DM, Wardle J, Duffy SW, Cuzick J, UK Flexible Sigmoidoscopy Trial Investigators Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.. vol.375, (9726) 1624 - 1633.
10.1016/S0140-6736(10)60551-X
Lancet2010
Chiu SY-H, Duffy S, Yen AM-F, Tabár L, Smith RA, Chen H-H Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening.. vol.19, (5) 1219 - 1228.
10.1158/1055-9965.EPI-09-1028
Cancer Epidemiol Biomarkers Prev2010
Raji OY, Agbaje OF, Duffy SW, Cassidy A, Field JK Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project.. vol.3, (5) 664 - 669.
10.1158/1940-6207.CAPR-09-0141
Cancer Prev Res (Phila)2010
Pinker K, Milner S, Mokbel K, Duffy S, Perry NM Mammographic density decreases with age as assessed by an objective integral automated breast density measurement system. vol.8, (3) 233 - 233.
10.1016/S1359-6349(10)70617-0
EJC SUPPLEMENTS2010
Duffy SW, Greenberg DC, Chou P, Brown CH, Purushotham AD, Wishart GC Reply to Explaining variations in survival in breast cancer in the Eastern Region of England.. vol.21, (3) 670 - 670.
10.1093/annonc/mdp572
Ann Oncol2010
Wishart GC, Greenberg DC, Chou P, Brown CH, Duffy S, Purushotham AD Treatment and survival in breast cancer in the Eastern Region of England. vol.21, (2) 291 - 296.
10.1093/annonc/mdp301
ANN ONCOL2010
Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, Yen AMF, Smith RA Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England.. vol.17, (1) 25 - 30.
10.1258/jms.2009.009094
J Med Screen2010
Pinker K, Perry N, Milner S, Mokbel K, Duffy S Accuracy of breast cancer detection with full-field digital mammography and integral computer-aided detection correlated with breast density as assessed by a new automated volumetric breast density measurement system. vol.12, () .
10.1186/bcr2657
BREAST CANCER RESEARCH2010
Lip G, Zakharova N, Duffy SW, Gillan MGC, Gilbert FJ Breast density as a predictor of breast cancer risk. vol.12, () .
10.1186/bcr2654
BREAST CANCER RESEARCH2010
Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA Cancer mortality in the 50-69 year age group before and after screening.. vol.17, (3) 159 - 160.
10.1258/jms.2010.010083
J Med Screen2010
Warwick J, Oram D, Covens A, Duffy S, Reynolds K Defining the surgical management of suspected early-stage ovarian cancer by estimating patient numbers through alternative management strategies. vol.117, (1) 114 - 116.
10.1111/j.1471-0528.2009.02429.x
BJOG-INT J OBSTET GY2010
Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA Duffy and colleagues reply.. vol.17, (2) 103.
10.1258/jms.2010.010060
J Med Screen2010
Duffy SW Epidemiology of female breast cancer. vol., () 1 - 12.
10.1017/CBO9780511676314.004
2010
Pinker K, Perry N, Milner S, Mokbel K, Duffy S Sensitivity of integral computer-aided detection with full-field digital mammography for detection of breast cancer according to different histopathological tumor types and appearances. vol.12, () .
10.1186/bcr2666
BREAST CANCER RESEARCH2010
Mayerhoefer M, Perry N, Milner S, Mokbel K, Duffy S, Pinker K Texture analysis applied to full-field digital mammography: ability to discriminate between invasive ductal and invasive lobular breast cancer - preliminary results. vol.12, () .
10.1186/bcr2665
BREAST CANCER RESEARCH2010
Stone J, Ding J, Warren RML, Duffy SW, Hopper JL Using mammographic density to predict breast cancer risk: dense area or percentage dense area. vol.12, (6) .
10.1186/bcr2778
BREAST CANCER RES2010
Pinker K, Perry N, Milner S, Mokbel K, Duffy S Validation of a new automated volumetric breast density measurement system as a marker of breast cancer risk. vol.12, () .
10.1186/bcr2648
BREAST CANCER RESEARCH2010
Zakharova NA, Duffy SW, Mackay J, Kotliarov EV [Evaluation of the screening program for early diagnosis of breast cancer in the Khanty-Mansy Autonomous Region-Yugra].. vol.56, (5) 609 - 612.Vopr Onkol2010
Field JK, Liloglou T, Niaz A, Bryan J, Gosney JR, Giles T, Brambilla C, Brambilla E, Vesin A, Timsit J-F, Hainaut P, Martinet Y, Vignaud JM, Thunnissen FB, Prinsen C, Snijders PJ, Smit EF, Sozzi G, Roz L, Risch A EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.. vol.34, (6) 1477 - 1486.
10.1183/09031936.00077809
Eur Respir J2009
Dawson SJ, Duffy SW, Blows FM, Driver KE, Provenzano E, LeQuesne J, Greenberg DC, Pharoah P, Caldas C, Wishart GC Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival. vol.101, (8) 1338 - 1344.
10.1038/sj.bjc.6605317
BRIT J CANCER2009
Duffy SW, Raji OY, Agbaje OF, Allgood PC, Cassidy A, Field JK Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer.. vol.9, (10) 1467 - 1472.
10.1586/era.09.87
Expert Rev Anticancer Ther2009
Duffy SW Cost of a 5-year lung cancer survivor. vol.101, (6) 881 - 881.
10.1038/sj.bjc.6605254
BRIT J CANCER2009
Zakharova N, Mackay J, Duffy S, Belyavsky A, Filimonov A, Kotlyarov Y Breast cancer screening program in Khanty-Mansiysk autonomous Okrug - Yugra. vol.7, (2) 314 - 315.EJC SUPPLEMENTS2009
Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW Early detection of second breast cancers improves prognosis in breast cancer survivors. vol.20, (9) 1505 - 1510.
10.1093/annonc/mdp037
ANN ONCOL2009
Raji OY, Agbaje OF, Duffy SW, Field JK The predictive ability of LLP lung cancer risk model with and without seizure 6-Like (SEZ6L) gene. vol.4, (9) S408 - S409.J THORAC ONCOL2009
Warwick J, Vardaki E, Fattizzi N, McNeish I, Jeyarajah A, Oram D, Hassan L, Covens A, Duffy S, Reynolds K Defining the surgical management of suspected early-stage ovarian cancer by estimating patient numbers through alternative management strategies.. vol.116, (9) 1225 - 1241.
10.1111/j.1471-0528.2009.02213.x
BJOG2009
Wald NJ, Law MR, Duffy SW Breast screening Breast screening saves lives. vol.339, () .
10.1136/bmj.b2922
BRIT MED J2009
Wald NJ, Law MR, Duffy SW Breast screening saves lives.. vol.339, () b2922.
10.1136/bmj.b2922
BMJ2009
Lawrence G, Wallis M, Allgood P, Nagtegaal ID, Warwick J, Cafferty FH, Houssami N, Kearins O, Tappenden N, O'Sullivan E, Duffy SW Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias. vol.116, (1) 179 - 185.
10.1007/s10549-008-0100-8
BREAST CANCER RES TR2009
Britton P, Duffy SW, Sinnatamby R, Wallis MG, Barter S, Gaskarth M, O'Neill A, Caldas C, Brenton JD, Forouhi P, Wishart GC One-stop diagnostic breast clinics: how often are breast cancers missed?. vol.100, (12) 1873 - 1878.
10.1038/sj.bjc.6605082
BRIT J CANCER2009
Duffy SW Commentary on 'what is the point: will screening mammography save my life?' by Keen and Keen.. vol.9, () 19.
10.1186/1472-6947-9-19
BMC Med Inform Decis Mak2009
Cafferty FH, Sasieni PD, Duffy SW A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillance.. vol.18, (2) 163 - 182.
10.1177/0962280208089091
Stat Methods Med Res2009
Pashayan N, Duffy SW, Pharoah P, Greenberg D, Donovan J, Martin RM, Hamdy F, Neal DE Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening. vol.100, (7) 1198 - 1204.
10.1038/sj.bjc.6604973
BRIT J CANCER2009
Prospective Studies Collaboration , Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.. vol.373, (9669) 1083 - 1096.
10.1016/S0140-6736(09)60318-4
Lancet2009
Cuzick J, Warwick J, Pinney L, Warren R, Cawthorn S, Howell A, Duffy S Change in breast density as a biomarker of breast cancer risk reduction; results from IBIS-1.. vol.69, (2) 77S - 78S.CANCER RESEARCH2009
Duffy SW, Lynge E, Jonsson H Reply: Estimation of lead-time and overdiagnosis in breast cancer screening. vol.100, (1) 220 - 220.
10.1038/sj.bjc.6604824
BRIT J CANCER2009
Holmberg L, Duffy SW, Yen AMF, Tabar L, Vitak B, Nystrom L, Frisell J Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: methodological consequences. vol.16, (2) 73 - 80.
10.1258/jms.2009.008103
J MED SCREEN2009
Gillan MGC, Gilbert FJ, Flight H, Cooper J, Wallis MG, James JJ, Boggis CRM, Astley SM, Agbaje OF, Duffy SW Increasing participant recruitment into large-scale screening trials: experience from the CADET II study. vol.16, (4) 180 - 185.
10.1258/jms.2009.009023
JOURNAL OF MEDICAL SCREENING2009
Pashayan N, Pharoah P, Neal DE, Hamdy F, Donovan J, Martin RM, Greenberg D, Duffy SW Stage shift in PSA-detected prostate cancers - effect modification by Gleason score. vol.16, (2) 98 - 101.
10.1258/jms.2009.009037
J MED SCREEN2009
Brain K, Henderson BJ, Tyndel S, Bankhead C, Watson E, Clements A, Austoker J, PIMMS Study Management Group Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme.. vol.17, (12) 1180 - 1188.
10.1002/pon.1355
Psychooncology2008
Gilbert FJ, Astley SM, Gillan MGC, Agbaje OF, Wallis MG, James J, Boggis CRM, Duffy SW, CADET II Grp Single reading with computer-aided detection for screening mammography. vol.359, (16) 1675 - 1684.
10.1056/NEJMoa0803545
NEW ENGL J MED2008
Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH Complexities in the estimation of overdiagnosis in breast cancer screening.. vol.99, (7) 1176 - 1178.
10.1038/sj.bjc.6604638
Br J Cancer2008
Smith RA, Field JK, Duffy SW A global approach to cancer-screening trials. vol.9, (10) 908 - 909.
10.1016/S1470-2045(08)70211-0
LANCET ONCOL2008
Duffy SW, Bowen RL, Ryan DA, Hart IR, Jones JL Reply: Early onset of breast cancer in black British women: how reliable are the findings?. vol., () .
10.1038/sj.bjc.6604626
Br J Cancer2008
Field JK, Duffy SW Lung cancer screening: the way forward. vol.99, (4) 557 - 562.
10.1038/sj.bjc.6604509
BRIT J CANCER2008
Ciatto S, Houssami N, Martinelli F, Bonardi R, Cafferty FH, Duffy SW Second breast cancers in a Tuscan case series: characteristics, prognosis, and predictors of survival. vol.99, (3) 539 - 544.
10.1038/sj.bjc.6604481
BRIT J CANCER2008
Duffy SW, Nagtegaal ID, Wallis M, Cafferty FH, Houssami N, Warwick J, Allgood PC, Kearins O, Tappenden N, O'Sullivan E, Lawrence G Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival.. vol.168, (1) 98 - 104.
10.1093/aje/kwn120
Am J Epidemiol2008
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL Reply: Early onset of breast cancer in British black women. vol.98, (12) 2012.
10.1038/sj.bjc.6604416
British Journal of Cancer2008
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL Early onset of breast cancer in British black women - Reply. vol.98, (12) 2012 - 2012.
10.1038/sj.bjc.6604416
BRIT J CANCER2008
Wishart GC, Greenberg DC, Britton PD, Chou P, Brown CH, Purushotham AD, Duffy SW Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?. vol.98, (11) 1741 - 1744.
10.1038/sj.bjc.6604368
BRIT J CANCER2008
Gilbert FJ, Astley SM, Gillan MG, Agbaje OF, Wallis MG, James J, Boggis CR, Duffy SW, Grp CADETII CADET II: A prospective trial of computer-aided detection (CAD) in the UK Breast Screening Programme. vol.26, (15) .JOURNAL OF CLINICAL ONCOLOGY2008
Perry NM, Allgood PC, Duffy SW, Mokbel K Exposure to traffic emissions throughout life and risk of breast cancer.. vol.19, (4) 435.
10.1007/s10552-007-9101-x
Cancer Causes Control2008
Bowen R, Duffy S, Ryan D, Hart I, Jones L Reply: Early onset breast cancer in black British women: a letter to the editor of British Journal of Cancer regarding early onset of breast cancer in a group of British black women. vol.98, (8) 1483 - 1484.
10.1038/sj.bjc.6604337
BRIT J CANCER2008
Duffy S, Blamey RW, UKCCCR Breast Cancer Frequency Tri Long-term mortality results from the UK Breast Screening Frequency Trial. vol.6, (7) 48 - 48.
10.1016/S1359-6349(08)70316-1
EJC SUPPLEMENTS2008
Pal A, Provenzano E, Duffy SW, Pinderl SE, Purushotham AD A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. vol.95, (3) 302 - 309.
10.1002/bjs.5943
BRIT J SURG2008
Perry NM, Allgood PC, Milner SE, Mokbel K, Duffy SW Mammographic breast density by area of residence: possible evidence of higher density in urban areas. vol.24, (2) 365 - 368.
10.1185/030079908X260907
CURR MED RES OPIN2008
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL Early onset of breast cancer in a group of British black women.. vol.98, (2) 277 - 281.
10.1038/sj.bjc.6604174
Br J Cancer2008
Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, Field JK The LLP risk model: an individual risk prediction model for lung cancer. vol.98, (2) 270 - 276.
10.1038/sj.bjc.6604158
BRIT J CANCER2008
Allgood PC, Warwick J, Warren RML, Day NE, Duffy SW A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality.. vol.98, (1) 206 - 209.
10.1038/sj.bjc.6604123
Br J Cancer2008
Duffy SW, Olsen AH, Gabe R, Tabar L, Warwick J, Fielder H, Tryggvadottir L, Agbaje OF Screening opportunity bias in case-control studies of cancer screening. vol.35, (5) 537 - 546.
10.1080/02664760701835755
J APPL STAT2008
Gilbert FJ, Astley SM, Boggis CRM, Mcgee MA, Griffiths PM, Duffy SW, Agbaje OF, Gillan MGC, Wilson M, Jain AK, Barr N, Beetles UM, Griffiths MA, Johnson J, Roberts RM, Deans HE, Duncan KA, Iyengar G Variable size computer-aided detection prompts and mammography film reader decisions. vol.10, (4) .
10.1186/bcr2137
BREAST CANCER RES2008
Duffy SW, Nagtegaal ID, Astley SM, Gillan MGC, McGee MA, Boggis CRM, Wilson M, Beetles UM, Griffiths MA, Jain AK, Johnson J, Roberts R, Deans H, Duncan KA, Iyengar G, Griffiths PM, Warwick J, Cuzick J, Gilbert FJ Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view.. vol.10, (4) R64.
10.1186/bcr2123
Breast Cancer Res2008
Prospective Studies Collaboration , Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.. vol.370, (9602) 1829 - 1839.
10.1016/S0140-6736(07)61778-4
Lancet2007
Jones JL, Thomas GJ, Duffy SW, Gabe R, Ellis I, Green A, Saha A, Mulligan KT, Ryder K, Gillet C, Violette S, Weinreb P, Hart IR, Marshall JF Expression of alphavbeta6 supersedes Her2 and triple-negative/basal classification of breast cancer and defines novel subgroups with poor survival: implications for breast cancer classification and treatment. vol.106, () S11 - S11.BREAST CANCER RESEARCH AND TREATMENT2007
Hughes S, Agbaje O, Bowen RL, Holliday DL, Shaw JA, Duffy S, Jones JL Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.. vol.13, (22 Pt 1) 6673 - 6680.
10.1158/1078-0432.CCR-07-0884
Clin Cancer Res2007
Gabe R, Tryggvadóttir L, Sigfússon BF, Olafsdóttir GH, Sigurdsson K, Duffy SW A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death.. vol.48, (9) 948 - 955.
10.1080/02841850701501725
Acta Radiol2007
Gorlov IP, Meyer P, Lilogiou T, Myles J, Boettger MB, Cassidy A, Girard L, Minna JD, Fischer R, Duffy S, Spitz MR, Haeussinger K, Kammerer S, Cantor C, Dierkesmann R, Field JK, Amos CI Seizure 6-like (SEZ6L) gene and risk for lung cancer. vol.67, (17) 8406 - 8411.
10.1158/0008-5472.CAN-06-4784
CANCER RES2007
Field JK, Cassidy A, Miles J, Liloglou T, Xinarianos G, Smith D, Niaz A, Page R, Duffy S Biomarkers and risk models for stratification of high risk individuals. vol.2, (8) S176 - S176.
10.1097/01.JTO.0000282955.20898.72
J THORAC ONCOL2007
Cafferty FH, Wong J-M, Yen AM-F, Duffy SW, Atkin WS, Chen TH-H Findings at follow-up endoscopies in subjects with suspected colorectal abnormalities: effects of baseline findings and time to follow-up.. vol.13, (4) 263 - 270.
10.1097/PPO.0b013e318046ebf1
Cancer J2007
Purushotham AD, Bennett Britton TM, Klevesath MB, Chou P, Agbaje OF, Duffy SW Lymph node status and breast cancer-related lymphedema.. vol.246, (1) 42 - 45.
10.1097/01.sla.0000259390.51203.7b
Ann Surg2007
Duffy SW Case-Control Studies to Evaluate the Effect of Mammographic Service Screening on Mortality from Breast Cancer. vol.10, (2) 61 - 63.
10.1053/j.sembd.2007.09.001
Seminars in Breast Disease2007
Swedish Organised Service Screening Evaluation Group Effect of mammographic service screening on stage at presentation of breast cancers in Sweden.. vol.109, (11) 2205 - 2212.
10.1002/cncr.22671
Cancer2007
Duffy SW, Chen THH, Yen AMF, Tabar L, Gabe R, Smith RA Methodologic Issues in the Evaluation of Service Screening. vol.10, (2) 68 - 71.
10.1053/j.sembd.2007.09.003
Seminars in Breast Disease2007
Duffy SW, Jonsson H, Agbaje OF, Pashayan N, Gabe R Avoiding bias from aggregate measures of exposure.. vol.61, (5) 461 - 463.
10.1136/jech.2006.050203
J Epidemiol Community Health2007
DUFFY S Case-control studies of breast cancer screening. vol., () .Seminars in breast disease2007
Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK Lung cancer risk prediction: A tool for early detection. vol.120, (1) 1 - 6.
10.1002/ijc.22331
INT J CANCER2007
Cuzick J, Cafferty FH, Edwards R, Møller H, Duffy SW Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial.. vol.14, (4) 178 - 185.
10.1258/096914107782912059
J Med Screen2007
Cassidy A, Myles JP, Duffy SW, Liloglou T, Field JK Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives. vol.95, (9) 1288 - 1290.
10.1038/sj.bjc.6603386
BRIT J CANCER2006
Duffy SW, Tabar L, Cherr THH, Yen AMF, Dean PB, Smith RA What information should be given to women invited for mammographic screening for breast cancer?. vol.2, (6) 829 - 833.
10.2217/17455057.2.6.829
Women's Health2006
Gilbert FJ, Astley SM, Mcgee MA, Gillan MGC, Boggis CRM, Griffiths PM, Duffy SW Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom national breast screening program. vol.241, (1) 47 - 53.
10.1148/radiol.2411051092
RADIOLOGY2006
Pashayan N, Powles J, Brown C, Duffy SW Erratum: Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia (British Journal of Cancer (2006) 95, (401-405) DOI: 10.1038/sj.bjc.6603246). vol.95, (5) 660.
10.1038/sj.bjc.6603330
British Journal of Cancer2006
Hughes S, Holliday D, Shaw J, Duffy S, Hart I, Jones L Analysis of MMP single nucleotide polymorphisms in relation to breast cancer progression. vol.210, () 58 - 58.JOURNAL OF PATHOLOGY2006
Pashayan N, Powles J, Brown C, Duffy SW Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia. vol.95, (3) 401 - 405.
10.1038/sj.bjc.6603246
BRIT J CANCER2006
Pashayan N, Powles J, Brown C, Duffy SW Incidence trends of prostate cancer in East Anglia, before and during the era of PSA diagnostic testing. vol.95, (3) 398 - 400.
10.1038/sj.bjc.6603247
BRIT J CANCER2006
Allgood PC, Duffy SW, Warren R, Hunnam G Audit of negative assessments in a breast-screening programme in women who later develop breast cancer-implications for survival.. vol.15, (4) 503 - 509.
10.1016/j.breast.2005.10.002
Breast2006
Buzdar A, Chlebowski R, Cuzick J, Duffy S, Forbes J, Jonat W, Ravdin P, Int Aromatase Inhibitor Expert Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer. vol.22, (8) 1575 - 1585.
10.1185/030079906X120940
CURR MED RES OPIN2006
Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.. vol.12, (4) 338 - 342.
10.1111/j.1075-122X.2006.00272.x
Breast J2006
Maurice A, Evans DGR, Shenton A, Ashcroft L, Baildam A, Barr L, Byrne G, Bundred N, Boggis C, Wilson M, Duffy SW, Howell A Screening younger women with a family history of breast cancer - does early detection improve outcome?. vol.42, (10) 1385 - 1390.
10.1016/j.ejca.2006.01.055
EUR J CANCER2006
Field JK, Smith RA, Duffy SW, Berg CD, van Klaveren R, Henschke CI, Carbone D, Postmus PE, Paci E, Hirsch FR, Mulshine JL The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group.. vol.1, (5) 497 - 498.
10.1097/01243894-200606000-00020
J Thorac Oncol2006
Cassidy A, Myles JP, Liloglou T, Duffy SW, Field JK Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer. vol.28, (5) 1295 - 1301.INT J ONCOL2006
Smith RA, Caleffi M, Albert US, Chen THH, Duffy SW, Franceschi D, Nystrom L, Global Summit Early Detection Acce Breast cancer in limited-resource countries: Early detection and access to care. vol.12, (1) S16 - S26.
10.1111/j.1075-122X.2006.00200.x
BREAST J2006
Duffy SW Cancer screening in Asia. vol.13, () S1 - S1.J MED SCREEN2006
Warwick J, Duffy S, Gabe R Evaluating the impact of population-based mammography service screening on breast cancer mortality in Western Europe; recent results and methodological challenges.. vol.100, () S274 - S275.BREAST CANCER RESEARCH AND TREATMENT2006
Astley SM, Duffy SW, Boggis CRM, Wilson M, Barr NB, Beetles UM, Griffiths MA, Jain A, Johnson J, Roberts RM, Deans H, Duncan K, Iyengar G, Agbaje O, Griffiths PM, Mcgee MA, Gillan MGC, Gilbert FJ Mammography reading with computer-aided detection (CAD): Performance of different readers. vol.4046, () 97 - 104.DIGITAL MAMMOGRAPHY, PROCEEDINGS2006
Agbaje OF, Astley SM, Gillan MGC, Boggis CRM, Wilson M, Barr NB, Beetles UM, Griffiths MA, Jain A, Johnson J, Roberts RM, Deans H, Duncan K, Iyengar G, Griffiths PM, Mcgee MA, Duffy SW, Gilbert FJ Mammography reading with computer-aided detection (CAD): Single view vs two views. vol.4046, () 125 - 130.DIGITAL MAMMOGRAPHY, PROCEEDINGS2006
Duffy SW, Tabar L, Chen THH, Smith RA, Holmberg L, Jonsson H, Lenner P, Nystrom L, Tornberg S, Swedish Organised Service Screenin Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. vol.15, (1) 45 - 51.
10.1158/1055-9965.EPI-05-0349
CANCER EPIDEM BIOMAR2006
Duffy SW, Tabar L, Chen THH, Smith RA, Holmberg L, Jonsson H, Lenner P, Nystrom L, Tornberg S, Swedish Organised Service Screen Reduction in breast cancer mortality from the organised service screening with mammography: 2. Validation with alternative analytic methods. vol.15, (1) 52 - 56.
10.1158/1055-9965.EPI-05-0953
CANCER EPIDEM BIOMAR2006
Salama I, Mihaimeed F, Marshall J, Jazayeri M, Thomas G, Duffy S, Jones LJ S100A7 and the basal phenotype in breast cancer.. vol.100, () S159 - S159.BREAST CANCER RESEARCH AND TREATMENT2006
Duffy SW, McCann J, Godward S, Gabe R, Warwick J Some issues in screening for breast and other cancers.. vol.13 Suppl 1, () S28 - S34.J Med Screen2006
Gabe R, Duffy SW, Mackay J, Anderson E, Duffy S, Ellis T, Evans G, Fielder H, Gray J, Gui G, Mackay J, Macmillan D, Moss S, Sainsbury R, Sibbering M, Thomas S, Warren R, Watson E, Boggis C, Burn J The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. vol.13, (4) 177 - 182.
10.1177/096914130601300404
J MED SCREEN2006
Duffy SW, Tabar L, Vitak B, Warwick J Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?. vol.12 Suppl 1, () S91 - S95.
10.1111/j.1075-122X.2006.00207.x
Breast J2006
Duffy SW Update on the FH01 study. vol.8, () S7 - S7.
10.1186/bcr1444
BREAST CANCER RESEARCH2006
Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwick J Estimates of overdiagnosis from two trials of mammographic screening for breast cancer. vol.7, (6) 258 - 265.
10.1186/bcr1354
Breast Cancer Research2005
Field JK, Smith DL, Duffy S, Cassidy A The Liverpool Lung Project research protocol. vol.27, (6) 1633 - 1645.INT J ONCOL2005
Duffy SW, Smith RA, Tabar L Re: Efficacy of breast cancer screening in the community according to risk level. vol.97, (22) 1703 - 1703.
10.1093/jnci/dji379
J NATL CANCER I2005
Duffy SW, Smith RA, Gabe R, Tabár L, Yen AMF, Chen THH Screening for breast cancer.. vol.14, (4) 671 - 697.
10.1016/j.soc.2005.06.001
Surg Oncol Clin N Am2005
Field J, Xinarianos G, Myles J, Nikolaidis G, Cassidy A, Duffy S, Liloglou T Lung cancer susceptibility: A CDKN1A promoter polymorphism enhances the risk for lung cancer. vol.49, () S82 - S82.LUNG CANCER2005
Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.. vol.23, (19) 4312 - 4321.
10.1200/JCO.2005.03.228
J Clin Oncol2005
Cuzick J, Duffy S, Tyrer J A breast cancer prediction model - Authors' reply. vol.24, (10) 1612 - 1612.
10.1002/sim.2014
STAT MED2005
de Bock GH, Jacobi CE, Jonker MA, Nagelkerke NJD, van Houwelingen JC A breast cancer prediction model.. vol.24, (10) 1610 - 1612.
10.1002/sim.2013
Stat Med2005
Duffy SW Commentary: Axillary dissection in breast cancer updated. vol.14, (2) 83 - 84.
10.1016/j.breast.2004.09.007
BREAST2005
Klevesath MB, Pantel K, Duffy SW, Gough P, Bobrow L, Purushotham AD Metastatic pathways in early breast cancer. vol.92, () 65 - 65.BRITISH JOURNAL OF SURGERY2005
Duffy SW, Gabe R What should the detection rates of cancers be in breast screening programmes?. vol.92, (3) 597 - 600.
10.1038/sj.bjc.6602345
Br J Cancer2005
Duffy SW Lymph node status in screen-detected cancers. vol.92, (1) 3 - 4.
10.1038/sj.bjc.6602290
BRIT J CANCER2005
Tyrer J, Duffy SW, Cuzick J A breast cancer prediction model incorporating familial and personal risk factors (vol 23, pg 1111, 2004). vol.24, (1) 156 - 156.
10.1002/sim.1913
STAT MED2005
Warwick J, Duffy SW A review of cancer screening evaluation techniques, with some particular examples in breast cancer screening. vol.168, () 657 - 677.
10.1111/j.1467-985X.2005.00371.x
J ROY STAT SOC A STA2005
Gabe R, Duffy SW Evaluation of service screening mammography in practice: the impact on breast cancer mortality.. vol.16 Suppl 2, () ii153 - ii162.
10.1093/annonc/mdi718
Ann Oncol2005
Warwick J, Fielder H, Duffy S Mammographic screening only matters in the detectable preclinical period of breast cancer - Author response. vol.12, (2) 107 - 107.
10.1258/0969141053908267
J MED SCREEN2005
Paci E, Duffy S Overdiagnosis and overtreatment of breast cancer - Overdiagnosis and overtreatment in service screening. vol.7, (6) 266 - 270.
10.1186/bcr1339
BREAST CANCER RES2005
Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwick J Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.. vol.7, (6) 258 - 265.
10.1186/bcr1354
Breast Cancer Res2005
Duffy SW Some current issues in breast cancer screening.. vol.12, (3) 128 - 133.
10.1258/0969141054855319
J Med Screen2005
Tabar L, Chen HHT, Yen MFA, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW, Smith RA Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma - Suggestions for the reconsideration of current therapeutic practice and the TNM classification system. vol.101, (8) 1745 - 1759.
10.1002/cncr.20582
CANCER2004
Peacock C, Given-Wilson R, Duffy S Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: is this a reliable prognostic indicator?. vol.59, (9) 855.
10.1016/j.crad.2004.06.009
Clin Radiol2004
Smith RA, Duffy SW, Gabe R, Tabar L, Yen AMF, Chen THH The randomized trials of breast cancer screening: what have we learned?. vol.42, (5) 793 - +.
10.1016/j.rcl.2004.06.014
RADIOL CLIN N AM2004
Duffy SW, Warwick J, Williams ARW, Keshavarz H, Kaffashian F, Rohan TE, Nili F, Sadeghi-Hassanabadi A A simple model for potential use with a misclassified binary outcome in epidemiology.. vol.58, (8) 712 - 717.
10.1136/jech.2003.010546
J Epidemiol Community Health2004
Duffy SW, Jakes RW, Ng FC, Gao F Interaction of dense breast patterns with other breast cancer risk factors in a case-control study.. vol.91, (2) 233 - 236.
10.1038/sj.bjc.6601911
Br J Cancer2004
Tabar L, Yen MF, Vitak B, Chen NN, Smith RA, Duffy SW Mammography service screening and mortality. vol.58, (4) 269 - 270.
10.1016/j.biopha.2004.03.002
BIOMED PHARMACOTHER2004
Wong JM, Yen MF, Lai MS, Duffy SW, Smith RA, Chen THH Progression rates of colorectal cancer by Dukes' stage in a high-risk group: Analysis of selective colorectal cancer screening. vol.10, (3) 160 - 169.
10.1097/00130404-200405000-00005
CANCER J2004
Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW Tamoxifen and breast density in women at increased risk of breast cancer.. vol.96, (8) 621 - 628.
10.1093/jnci/djh106
J Natl Cancer Inst2004
Tyrer J, Duffy SW, Cuzick J A breast cancer prediction model incorporating familial and personal risk factors.. vol.23, (7) 1111 - 1130.
10.1002/sim.1668
Stat Med2004
Warwick J, Tabàr L, Vitak B, Duffy SW Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study.. vol.100, (7) 1331 - 1336.
10.1002/cncr.20140
Cancer2004
Paci E, Duffy S, Falini R, Warvick J An estimate of the overdiagnosis in service screening: an evaluation in the Florence City Program. vol.2, (3) 89 - 89.
10.1016/S1359-6349(04)90722-7
EJC SUPPL2004
Voogd AC, Ernst MF Comment on "The relative contributions of screen-detected in-situ and invasive breast carcinomas in reducing mortality from the disease" by S.W. Duffy, L. Tabar, B. Vitak et al.. vol.40, (5) 774 - 775.
10.1016/j.ejca.2003.11.018
Eur J Cancer2004
Duffy SW, Tabar L, Smith RA Reply to comment on "The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease" by A.C. Voogd, M.F. Ernst. vol.40, (5) 776 - 777.
10.1016/j.ejca.2003.11.017
EUR J CANCER2004
Peacock C, Given-Wilson RM, Duffy SW Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: is this a reliable prognostic indicator?. vol.59, (2) 165 - 170.
10.1016/j.crad.2003.07.006
CLIN RADIOL2004
Myles JP, Salmininen T, Duffy SW, Prevost TC, Day NE, Hakama M Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy.. vol.13, (1) 56 - 60.
10.1016/j.breast.2003.10.007
Breast2004
Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, Duffy SW A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. vol.11, (4) 194 - 198.
10.1258/0969141042467304
J MED SCREEN2004
Warren R, Allgood P, Hunnam G, Godward S, Duffy S, E Anglian Breast Screening Program An audit of assessment procedures in women who develop breast cancer after a negative result. vol.11, (4) 180 - 186.
10.1258/0969141042467395
J MED SCREEN2004
Cuzick J, DUFFY SW, Warren RML, Pinney E, Warwick J Effect of tamoxifen on women at increased risk of breast cancer.. vol.96, () 621 - 628.J Natl. Cancer Institute.2004
DUFFY SW, Warwick J, Vitak B, Tabar L Long-term survival with breast cancer: evidence from the Swedish Two-County study (1977-98).. vol.3, () 376 - 385.Am J Oncol Rev.2004
McCann J, Treasure P, Duffy S Modelling the impact of detecting and treating carcinoma in situ in a breast screening programme. vol.11, (3) 117 - 125.
10.1258/0969141041732201
J MED SCREEN2004
Tabar L, Vitak B, Yen MFA, Chen HHT, Smith RA, Duffy SW Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. vol.11, (3) 126 - 129.
10.1258/0969141041732175
J MED SCREEN2004
Paci E, Warwick J, Falini P, Duffy SW Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?. vol.11, (1) 23 - 27.
10.1177/096914130301100106
J MED SCREEN2004
Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Pollard S, Clack G, Cuzick J, Coibion M, Bianco AR The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.. vol.110, (12) 1099 - 1106.
10.1111/j.1471-0528.2003.02120.x
BJOG2003
Kaffashian F, Godward S, Davies T, Solomon L, McCann J, Duffy SW Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology. vol.89, (9) 1693 - 1696.
10.1038/sj.bjc.6601339
BRIT J CANCER2003
Nixon RM, Duffy SW, Fender GRK Imputation of a true endpoint from a surrogate: Application to a cluster randomized controlled trial with partial information on the true endpoint. vol.3, () 1 - 11.
10.1186/1471-2288-3-17
BMC Medical Research Methodology2003
Nixon RM, Duffy SW, Fender GRK Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint.. vol.3, () 17.
10.1186/1471-2288-3-17
BMC Med Res Methodol2003
Liu WJ, Lee LT, Yen MF, Tung TH, Williams R, Duffy SW, Chen THH Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan. vol.20, (9) 727 - 733.
10.1046/j.1464-5491.2003.01019.x
DIABETIC MED2003
Duffy SW, Rohan TE, Kandel R, Prevost TC, Rice K, Myles JP Misclassification in a matched case-control study with variable matching ratio: application to a study of c-erbB-2 overexpression and breast cancer.. vol.22, (15) 2459 - 2468.
10.1002/sim.1477
Stat Med2003
Myles JP, Price GM, Hunter N, Day M, Duffy SW A potentially useful distribution model for dietary intake data.. vol.6, (5) 513 - 519.
10.1079/PHN2003459
Public Health Nutr2003
Yen M-F, Tabár L, Vitak B, Smith RA, Chen H-H, Duffy SW Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.. vol.39, (12) 1746 - 1754.
10.1016/S0959-8049(03)00260-0
Eur J Cancer2003
Duffy SW, Tabar L, Vitak B, Yen MF, Warwick J, Smith RA, Chen HH The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.. vol.14, (8) 1196 - 1198.
10.1093/annonc/mdg322
Ann Oncol2003
Duffy SW, Tabar L, Vitak B, Day NE, Smith RA, Chen HHT, Yen MFA The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.. vol.39, (12) 1755 - 1760.
10.1016/S0959-8049(03)00259-4
Eur J Cancer2003
Tabar L, Duffy SW, Smith RA Mammography service screening and mortality - Reply. vol.362, (9380) 330 - 330.
10.1016/S0140-6736(03)13983-9
LANCET2003
Gøtzsche PC Mammography service screening and mortality.. vol.362, (9380) 329 - 330.
10.1016/S0140-6736(03)13982-7
Lancet2003
Myles JP, Nixon RM, Duffy SW, Tabar L, Boggis C, Evans G, Shenton A, Howell A Bayesian evaluation of breast cancer screening using data from two studies. vol.22, (10) 1661 - 1674.
10.1002/sim.1365
STAT MED2003
Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom LO, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Salander H, Save-Soderbergh J, Wahlin T The Gothenburg Breast Screening Trial. vol.97, (10) 2387 - 2396.
10.1002/cncr.11361
CANCER2003
Tabar L, Yen MF, Vitak B, Chen HHT, Smith RA, Duffy SW Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. vol.361, (9367) 1405 - 1410.
10.1016/S0140-6736(03)13143-1
LANCET2003
Jakes RW, Duffy SW Correspondence re: Jakes et al., mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol Biomark. Prev., 11 : 608-613, 2002 - Reply. vol.12, (4) 387 - 387.CANCER EPIDEM BIOMAR2003
Warwick J, Pinney E, Warren RML, Duffy SW, Howell A, Wilson M, Cuzick J Breast density and breast cancer risk factors in a high-risk population.. vol.12, (1) 10 - 16.
10.1016/S0960-9776(02)00212-6
Breast2003
Warren RML, Young JR, McLean L, Lyons K, Wilson ARM, Evans A, Duffy SW, Warsi IM Radiology review of the UKCCCR breast screening frequency trial: Potential improvements in sensitivity and lead time of radiological signs. vol.58, (2) 128 - 132.
10.1053/crad.2002.1132
CLIN RADIOL2003
DUFFY SW, Sala E, Bjorneld L, Warwick J, Bjurstam N Age-specific effects of beast cancer screening: the randomized breast screening trial in Gothenburg.. vol.2, () 435 - 442.Amer. J. Oncol. Rev.2003
Miller AB, To T, Baines CJ, Wall C, Duffy SW Annual mammography and breast examination did not reduce breast cancer mortality in women aged 40-49 years. vol.5, (1) 46 - 47.
10.1016/S1361-259X(03)00006-0
Evidence-based Obstetrics and Gynecology2003
DUFFY SW, Patel DD, Bala DV Breast cancer, reported dietary intakes and dietary biomarkers: a case-control study in Gujarat, India.. vol.3, () 219 - 230.Res. Adv. Cancer2003
DUFFY SW Commentary on CNBSS-1. vol.5, () 47.Evidence Based Obstet Gynaecol2003
Tabar L, Smith RA, Vitak B, Yen MF, Chen THH, Warwick J, Myles JP, Duffy SW Mammographic screening: A key factor in the control of breast cancer. vol.9, (1) 15 - 27.
10.1097/00130404-200301000-00004
CANCER J2003
Jackson CH, Sharples LD, Thompson SG, Duffy SW, Couto E Multistate Markov models for disease progression with classification error. vol.52, () 193 - 209.
10.1111/1467-9884.00351
J ROY STAT SOC D-STA2003
Duffy SW The controversy over breast cancer screening. vol.63, (12) 708 - 709.
10.12968/hosp.2002.63.12.1889
HOSP MED2002
Smith R, Duffy S, Tabar L The mammographic screening trials: Commentary on the recent work by Olsen and Gotzsche (Reprinted from A Cancer Journal for Clinicians, vol 52, pg 68-71, 2002) - Reply. vol.81, (4) 164 - 166.
10.1002/jso.10196
J SURG ONCOL2002
Duffy S, Tabár L, Smith RA The mammographic screening trials: commentary on the recent work by Olsen and Gøtzsche.. vol.81, (4) 159 - 162.
10.1002/jso.10193
J Surg Oncol2002
Beral V, Hamajima N, Hirose K, Rohan T, Calle EE, Heath CW, Coates RJ, Liff JM, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Morabia A, Schuman L, Stewart W, Szklo M, Bain C, Schofield F, Siskind V, Band P Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease. vol.87, (11) 1234 - 1245.
10.1038/sj.bjc.6600596
BRIT J CANCER2002
Harrison DA, Duffy SW, Sala E, Warren RML, Couto E, Day NE Deterministic models for breast cancer progression: Application to the association between mammographic parenchymal pattern and histologic grade of breast cancers. vol.55, (11) 1113 - 1118.
10.1016/S0895-4356(02)00483-3
J CLIN EPIDEMIOL2002
Liao C-S, Yang K-C, Yen M-F, Teng L-L, Duffy SW, Chen TH-H Prognosis of small hepatocellular carcinoma treated by percutaneous ethanol injection and transcatheter arterial chemoembolization.. vol.55, (11) 1095 - 1104.
10.1016/S0895-4356(02)00487-0
J Clin Epidemiol2002
Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, Bianchi S, Cataliotti L, del Turco MR Are breast cancer screening programmes increasing rates of mastectomy? Observational study.. vol.325, (7361) 418.
10.1136/bmj.325.7361.418
BMJ2002
Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, Wiege M, Akerlund A, Wu HM, Tung TS, Chiu YH, Chiu CP, Huang CC, Smith RA The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties - A collaborative evaluation. vol.95, (3) 458 - 469.
10.1002/cncr.10765
CANCER2002
Tabar L, Smith RA, Duffy SW Update on effects of screening mammography. vol.360, (9329) 337 - 337.
10.1016/S0140-6736(02)09523-5
LANCET2002
Tabár L, Smith RA, Duffy SW, Bonneux L, Gøtzsche PC, Cheng KK, Gulbrandsen P, Nyström L, Andersson I, Bjurstam N, Frisell J, Rutqvist LE Update on effects of screening mammography [1] (multiple letters). vol.360, (9329) 337 - 340.Lancet2002
Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP, Yu MC Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. vol.11, (7) 608 - 613.CANCER EPIDEM BIOMAR2002
Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, Bianchi S, del Turco MR Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96.. vol.87, (1) 65 - 69.
10.1038/sj.bjc.6600301
Br J Cancer2002
Breast Screening Frequency Trial Group The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research.. vol.38, (11) 1458 - 1464.
10.1016/S0959-8049(01)00397-5
Eur J Cancer2002
Chen TH-H, Chen C-J, Yen M-F, Lu S-N, Sun C-A, Huang G-T, Yang P-M, Lee H-S, Duffy SW Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.. vol.98, (2) 257 - 261.
10.1002/ijc.10122
Int J Cancer2002
Duffy SW, Tabar L, Smith RA The mammographic screening trials: Commentary on the recent work by Olsen and Gotzsche. vol.52, (2) 68 - 71.
10.3322/canjclin.52.2.68
CA-CANCER J CLIN2002
Duffy SW, Nixon RM Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutations.. vol.86, (2) 218 - 221.
10.1038/sj.bjc.6600064
Br J Cancer2002
Gøtzsche PC Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.. vol.94, (2) 578.
10.1002/cncr.10224
Cancer2002
Tabar L, Duffy SW, Yen MF, Warwick J, Vitak B, Chen HH, Smith RA All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. vol.9, (4) 159 - 162.
10.1136/jms.9.4.159
J MED SCREEN2002
Duffy SW, Cuzick J, Tabar L, Vitak B, Chen THH, Yen MF, Smith RA Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. vol.51, () 235 - 243.
10.1111/1467-9876.00266
J ROY STAT SOC C-APP2002
Nixon RM, Duffy SW Cross-issue synthesis: potential application to breast cancer, tamoxifen and genetic susceptibility.. vol.7, (4) 205 - 212.J Cancer Epidemiol Prev2002
Myles JP, Duffy SW, Prevost TC, Day NE, Hakama M, Salminen T Markov chain Monte Carlo inference applied to a complex model for the longitudinal analysis of breast patterns. vol.51, () 197 - 207.
10.1111/1467-9876.00263
J ROY STAT SOC C-APP2002
Couto E, Duffy SW, Ashton HA, Walker NM, Myles JP, Scott RAP, Thompson SG Probabilities of progression of aortic aneurysms: estimates and implications for screening policy. vol.9, (1) 40 - 42.
10.1136/jms.9.1.40
J MED SCREEN2002
Mackay J, Duffy SW Reply. vol.6, (5) 375.
10.1080/135952201753337031
Journal of Epidemiology and Biostatistics2001
Miller AB Screening for breast cancer with mammography.. vol.358, (9299) 2164.
10.1016/S0140-6736(01)07189-6
Lancet2001
Myles J, Duffy S, Nixon R, Boggis C, Howell A, Shenton A, Evans G Initial results of a study into the effectiveness of breast cancer screening in a population identified to be at high risk.. vol.49, (5) 471 - 475.Rev Epidemiol Sante Publique2001
Duffy SW, Cuzick J Let's talk about mammographic screening over again - response. vol.10, (5) 450 - 451.BREAST2001
Nixon RM, Duffy SW, Fender GR, Day NE, Prevost TC Randomization at the level of primary care practice: use of pre-intervention data and random effects models.. vol.20, (12) 1727 - 1738.
10.1002/sim.792
Stat Med2001
Scott RA, Vardulaki KA, Walker NM, Day NE, Duffy SW, Ashton HA The long-term benefits of a single scan for abdominal aortic aneurysm (AAA) at age 65.. vol.21, (6) 535 - 540.
10.1053/ejvs.2001.1368
Eur J Vasc Endovasc Surg2001
Tabár L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.. vol.91, (9) 1724 - 1731.
10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V
Cancer2001
Jakes RW, Alexander L, Duffy SW, Leong J, Chen LH, Lee WH Dietary intake of soybean protein and menstrual cycle length in pre-menopausal Singapore Chinese women.. vol.4, (2) 191 - 196.Public Health Nutr2001
Fender GR, Prentice A, Nixon RM, Gorst T, Duffy SW, Day NE, Smith SK Management of menorrhagia: an audit of practices in the Anglia menorrhagia education study.. vol.322, (7285) 523 - 524.
10.1136/bmj.322.7285.523
BMJ2001
McCann J, Duffy S, Day N, East Anglia Breast Screening Programme Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia.. vol.84, (3) 423 - 428.
10.1054/bjoc.2000.1609
Br J Cancer2001
Mackay J, Rogers C, Fielder H, Blamey R, Macmillan D, Boggis C, Brown J, Pharoah PD, Moss S, Day NE, Myles J, Austoker J, Gray J, Cuzick J, Duffy SW Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.. vol.6, (5) 365 - 369.
10.1080/135952201753337086
J Epidemiol Biostat2001
Couto E, Harrison D, Duffy S, Myles J, Sala E, Warren R, Day N, Luben R, Chen H Estimation of disease progression parameters from case-control data: application to mammographic patterns and breast cancer natural history.. vol.6, (2) 235 - 242.
10.1080/135952201753173015
J Epidemiol Biostat2001
Duffy SW Interpretation of the breast screening trials: A commentary on the recent paper by Gøtzsche and Olsen. vol.10, (3) 209 - 212.
10.1054/brst.2000.0238
Breast2001
De Nigris A, Paladini G, Duffy SW, Cuzick J Letter to the editor (multiple lettes) [1]. vol.10, (5) 450 - 451.Breast2001
Sala E, Warren R, McCann J, Duffy S, Luben R, Day N Mammographic parenchymal patterns and breast cancer natural history--a case-control study.. vol.40, (4) 461 - 465.
10.1080/028418601750288172
Acta Oncol2001
Schlecht NF, Franco EL, Rohan TE, Kjaer SK, Schiffman MH, Moscicki AB, Duffy SW, Marsh International Collaborative Group Repeatability of sexual history in longitudinal studies on HPV infection and cervical neoplasia: determinants of reporting error at follow-up interviews.. vol.6, (5) 393 - 407.
10.1080/135952201753337149
J Epidemiol Biostat2001
Keshavarz H, Duffy SW, Sadeghi-Hassanabadi A, Zolghadr Z, Oboodi B Risk factors for and relationship between bacterial vaginosis and cervicitis in a high risk population for cervicitis in Southern Iran.. vol.17, (1) 89 - 95.
10.1023/A:1010935723248
Eur J Epidemiol2001
Bala DV, Patel DD, Duffy SW, Cherman S, Patel PS, Trivedi J, Pinaki P, Pandey P, Patel R Role of dietary intake and biomarkers in risk of breast cancer: A case control study. vol.2, (2) 123 - 130.Asian Pacific Journal of Cancer Prevention2001
Sala E, Warren R, McCann J, Duffy S, Luben R, Day N High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study.. vol.29, (4) 629 - 636.
10.1093/ije/29.4.629
Int J Epidemiol2000
Nixon RM, Pharoah P, Tabar L, Krusemo UB, Duffy SW, Prevost TC, Chen HH Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.. vol.48, (4) 325 - 331.Rev Epidemiol Sante Publique2000
Sala E, Warren R, Duffy S, Welch A, Luben R, Day N High risk mammographic parenchymal patterns and diet: a case-control study.. vol.83, (1) 121 - 126.
10.1054/bjoc.2000.1151
Br J Cancer2000
Tabár L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, Krusemo UB, Tot T, Smith RA The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up.. vol.38, (4) 625 - 651.
10.1016/s0033-8389(05)70191-3
Radiol Clin North Am2000
Chappuis PO, Deschênes J, Foulkes WD Long-term outcome of invasive breast cancer.. vol.355, (9214) 1551.
10.1016/S0140-6736(00)02178-4
Lancet2000
Tabár L, Dean PB, Kaufman CS, Duffy SW, Chen HH A new era in the diagnosis of breast cancer.. vol.9, (2) 233 - 277.Surg Oncol Clin N Am2000
Andrieu N, Prevost T, Rohan TE, Luporsi E, Lê MG, Gerber M, Zaridze DG, Lifanova Y, Renaud R, Lee HP, Duffy SW Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality.. vol.29, (2) 214 - 223.
10.1093/ije/29.2.214
Int J Epidemiol2000
Chen TH, Kuo HS, Yen MF, Lai MS, Tabar L, Duffy SW Estimation of sojourn time in chronic disease screening without data on interval cases.. vol.56, (1) 167 - 172.
10.1111/j.0006-341X.2000.00167.x
Biometrics2000
Miller AB, Baines CJ, To T, Wall C Screening mammography re-evaluated.. vol.355, (9205) 747.
10.1016/S0140-6736(00)00031-3
Lancet2000
Tabár L, Chen HH, Duffy SW, Yen MF, Chiang CF, Dean PB, Smith RA A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study.. vol.355, (9202) 429 - 433.
10.1016/S0140-6736(00)82008-5
Lancet2000
Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women.. vol.29, (1) 11 - 19.
10.1093/ije/29.1.11
Int J Epidemiol2000
Vardulaki KA, Walker NM, Day NE, Duffy SW, Ashton HA, Scott RA Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm.. vol.87, (2) 195 - 200.
10.1046/j.1365-2168.2000.01353.x
Br J Surg2000
Warren R, Duffy S Interval cancers as an indicator of performance in breast screening.. vol.7, (1) 9 - 18.
10.1007/BF02967182
Breast Cancer2000
Sala E, Solomon L, Warren R, McCann J, Duffy S, Luben R, Day N Size, node status and grade of breast tumours: association with mammographic parenchymal patterns.. vol.10, (1) 157 - 161.
10.1007/s003300050025
Eur Radiol2000
Sala E, Warren R, McCann J, Duffy S, Luben R, Day N Smoking and high-risk mammographic parenchymal patterns: a case-control study.. vol.2, (1) 59 - 63.
10.1186/bcr29
Breast Cancer Res2000
Nixon R, Prevost TC, Duffy SW, Tabar L, Vitak B, Chen HH Some random-effects models for the analysis of matched-cluster randomised trials: application to the Swedish two-county trial of breast-cancer screening.. vol.5, (6) 349 - 358.J Epidemiol Biostat2000
Park PJ, Griffin SJ, Duffy SW, Wareham NJ The effect of varying the screening interval on false positives and duration of undiagnosed disease in a screening programme for type 2 diabetes.. vol.7, (2) 91 - 96.
10.1136/jms.7.2.91
J Med Screen2000
Sala E, Warren R, McCann J, Duffy S, Luben R, Day N High-risk mammographic parenchymal patterns and anthropometric measures: a case-control study.. vol.81, (7) 1257 - 1261.
10.1038/sj.bjc.6690838
Br J Cancer1999
Tabar L, Chen HH, Duffy SW, Krusemo UB Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening.. vol.29, (12) 608 - 616.
10.1093/jjco/29.12.608
Jpn J Clin Oncol1999
Tabar L, Duffy SW Criticisms of Swedish mammography trials were wrong.. vol.319, (7221) 1367.
10.1136/bmj.319.7221.1367
BMJ1999
Wong MY, Day NE, Bashir SA, Duffy SW Measurement error in epidemiology: the design of validation studies I: univariate situation.. vol.18, (21) 2815 - 2829.
10.1002/(SICI)1097-0258(19991115)18:21<2815::AID-SIM280>3.0.CO;2-#
Stat Med1999
Prospective Studies Collaboration Collaborative overview ('meta-analysis') of prospective observational studies of the associations of usual blood pressure and usual cholesterol levels with common causes of death: protocol for the second cycle of the Prospective Studies Collaboration.. vol.6, (5) 315 - 320.J Cardiovasc Risk1999
Chen TH, Yen MF, Lai MS, Koong SL, Wang CY, Wong JM, Prevost TC, Duffy SW Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project.. vol.86, (7) 1116 - 1128.
10.1002/(SICI)1097-0142(19991001)86:7<1116::AID-CNCR4>3.0.CO;2-D
Cancer1999
Tabár L, Duffy SW, Vitak B, Chen HH, Prevost TC The natural history of breast carcinoma: what have we learned from screening?. vol.86, (3) 449 - 462.
10.1002/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q
Cancer1999
Hormone replacement therapy. Clinical Synthesis Panel on HRT.. vol.354, (9173) 152 - 155.
10.1016/S0140-6736(99)06570-8
Lancet1999
Fender GR, Prentice A, Gorst T, Nixon RM, Duffy SW, Day NE, Smith SK Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study.. vol.318, (7193) 1246 - 1250.
10.1136/bmj.318.7193.1246
BMJ1999
Chen HH, Prevost TC, Duffy SW Evaluation of screening for nasopharyngeal carcinoma: trial design using Markov chain models.. vol.79, (11-12) 1894 - 1900.
10.1038/sj.bjc.6690301
Br J Cancer1999
Duffy SW, Keshavarz H, Sadeghi-Hassanabadi A, Zolghadr Z, Oboodi B Prevalence of cervicitis in women living in southern Iran.. vol.47, (1) 86.Rev Epidemiol Sante Publique1999
Iso H, Sato H, Chambless L, De Backer G, De Bacquer D, Kornitzer M, Ebrahim S, Whincup P, Wannamethee G, Wald N, Morris J, Knuimann M, Sweetnam P, Elwood P, Kronmal R, Kromhout D, Sutherland S, Keil J, Schnohr P, Jensen G Collaborative overview ('Meta-Analysis') of Prospective Observational Studies of the Associations of Usual Blood Pressure and Usual Cholesterol Levels with Common Causes of Death: Protocol for the Second Cycle of the Prospective Studies Collaboration. vol.6, (5) 315 - 320.
10.1177/204748739900600508
European Journal of Preventive Cardiology1999
Prevost TC, Rohan TE, Duffy SW, Chen HH, To T, Hill RD Markov chain models and estimation of absolute progression rates: application to cataract progression in diabetic adults.. vol.4, (4) 337 - 344.J Epidemiol Biostat1999
Tabar L, Vitak B, Chen HH, Prevost TC, Duffy SW Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results.. vol.5, (5) 199 - 204.
10.1024/1023-9332.5.5.199
Swiss Surg1999
Prevost TC, Spiegelhalter DJ, Duffy SW Use of person-years of CIN III exposure as a surrogate outcome measure in cervical cancer screening trials.. vol.4, (1) 19 - 29.J Epidemiol Biostat1999
Tabár L, Duffy SW, Chen HH Where now? The future of imaging of breast diseases. vol.10, (1) 32.Imaging1998
Launoy G, Duffy SW, Prevost TC, Bouvier V [Detection of cancer, sensitivity of the test and sensitivity of the screening program].. vol.46, (5) 420 - 426.Rev Epidemiol Sante Publique1998
Lai MS, Yen MF, Kuo HS, Koong SL, Chen TH, Duffy SW Efficacy of breast-cancer screening for female relatives of breast-cancer-index cases: Taiwan multicentre cancer screening (TAMCAS).. vol.78, (1) 21 - 26.
10.1002/(SICI)1097-0215(19980925)78:1<21::AID-IJC5>3.0.CO;2-Z
Int J Cancer1998
Prevost TC, Launoy G, Duffy SW, Chen HH Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches.. vol.148, (6) 609 - 619.
10.1093/oxfordjournals.aje.a009687
Am J Epidemiol1998
Miller AB, Baines CJ, To T The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.. vol.83, (1) 186 - 190.
10.1002/(SICI)1097-0142(19980701)83:1<186::AID-CNCR25>3.0.CO;2-S
Cancer1998
Chen HH, Thurfjell E, Duffy SW, Tabar L Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden.. vol.52, (5) 329 - 335.
10.1136/jech.52.5.329
J Epidemiol Community Health1998
Andrieu N, Smith T, Duffy S, Zaridze DG, Renaud R, Rohan T, Gerber M, Luporsi E, Lê M, Lee HP, Lifanova Y, Day NE The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies.. vol.77, (9) 1525 - 1536.
10.1038/bjc.1998.251
Br J Cancer1998
Seow A, Duffy SW, Ng TP, McGee MA, Lee HP Lung cancer among Chinese females in Singapore 1968-1992: time trends, dialect group differences and implications for aetiology.. vol.27, (2) 167 - 172.
10.1093/ije/27.2.167
Int J Epidemiol1998
Launoy G, Duffy SW, Prevost TC, Bouvier V Re: Fecal occult blood screening in the Minnesota study.. vol.90, (6) 465 - 467.
10.1093/jnci/90.6.465-a
J Natl Cancer Inst1998
Sala E, Warren R, McCann J, Duffy S, Day N, Luben R Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme.. vol.5, (4) 207 - 212.
10.1136/jms.5.4.207
J Med Screen1998
Bjurstam N, Björneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, Hafström LO, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Säve-Söderbergh J The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.. vol.80, (11) 2091 - 2099.
10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#
Cancer1997
Qizilbash N, Duffy S, Prentice CR, Boothby M, Warlow C Von Willebrand factor and risk of ischemic stroke.. vol.49, (6) 1552 - 1556.
10.1212/WNL.49.6.1552
Neurology1997
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.. vol.350, (9084) 1047 - 1059.
10.1016/S0140-6736(97)08233-0
Lancet1997
Warren RM, Duffy S A comparison of the effectiveness of 28 kV (grid) versus 25 kV (no grid) mammographic techniques for breast screening.. vol.70, (838) 1022 - 1027.
10.1259/bjr.70.838.9404206
Br J Radiol1997
Keshavarz H, Duffy SW, Sotodeh-Maram E, Saraf Z, Sadeghi-Hassana-Badi A, Zighami B, Tabei Z Factors related to cervicitis in Qashghaee nomadic women of southern Iran.. vol.45, (4) 279 - 285.Rev Epidemiol Sante Publique1997
Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA Family history and the risk of breast cancer: a systematic review and meta-analysis.. vol.71, (5) 800 - 809.
10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B
Int J Cancer1997
Howe GR, Aronson KJ, Benito E, Castelleto R, Cornée J, Duffy S, Gallagher RP, Iscovich JM, Deng-ao J, Kaaks R, Kune GA, Kune S, Lee HP, Lee M, Miller AB, Peters RK, Potter JD, Riboli E, Slattery ML, Trichopoulos D The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies.. vol.8, (2) 215 - 228.
10.1023/A:1018476414781
Cancer Causes Control1997
Bashir SA, Duffy SW, Qizilbash N Repeat measurement of case-control data: corrections for measurement error in a study of ischaemic stroke and haemostatic factors.. vol.26, (1) 64 - 70.
10.1093/ije/26.1.64
Int J Epidemiol1997
Bashir SA, Duffy SW The correction of risk estimates for measurement error.. vol.7, (2) 154 - 164.
10.1016/S1047-2797(96)00149-4
Ann Epidemiol1997
Chen HH, Duffy SW, Tabar L A mover-stayer mixture of Markov chain models for the assessment of dedifferentiation and tumour progression in breast cancer. vol.24, (3) 265 - 278.
10.1080/02664769723675
Journal of Applied Statistics1997
Duffy SW, Day NE, Tabár L, Chen HH, Smith TC Markov models of breast tumor progression: some age-specific results.. vol., (22) 93 - 97.
10.1093/jncimono/1997.22.93
J Natl Cancer Inst Monogr1997
Tabár L, Chen HH, Fagerberg G, Duffy SW, Smith TC Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening.. vol., (22) 43 - 47.
10.1093/jncimono/1997.22.43
J Natl Cancer Inst Monogr1997
Bjurstam N, Björneld L, Duffy SW, Smith TC, Cahlin E, Erikson O, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Säwe-Söderberg J The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49.. vol., (22) 53 - 55.
10.1093/jncimono/1997.22.53
J Natl Cancer Inst Monogr1997
Chen HH, Duffy SW, Tabar L A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening. vol.45, (3) 307 - 317.Journal of the Royal Statistical Society Series D: The Statistician1996
Duffy SW, Chen HH, Tabar L, Fagerberg G, Paci E Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49.. vol.25, (6) 1139 - 1145.
10.1093/ije/25.6.1139
Int J Epidemiol1996
Day NE, Duffy SW Trial design based on surrogate end points - Application to comparison of different breast screening frequencies. vol.159, (1) 49 - 60.Journal of the Royal Statistical Society. Series A: Statistics in Society1996
Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.. vol.347, (9017) 1713 - 1727.
10.1016/S0140-6736(96)90806-5
Lancet1996
Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A Tumour development, histology and grade of breast cancers: prognosis and progression.. vol.66, (4) 413 - 419.
10.1002/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z
Int J Cancer1996
Seow A, Duffy SW, McGee MA, Lee J, Lee HP Breast cancer in Singapore: trends in incidence 1968-1992.. vol.25, (1) 40 - 45.
10.1093/ije/25.1.40
Int J Epidemiol1996
Warren RM, Duffy SW, Bashir S The value of the second view in screening mammography.. vol.69, (818) 105 - 108.
10.1259/0007-1285-69-818-105
Br J Radiol1996
Tabár L, Duffy SW, Chen HH Re: Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials.. vol.88, (1) 52 - 55.
10.1093/jnci/88.1.52-a
J Natl Cancer Inst1996
Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.. vol.346, (8991-8992) 1647 - 1653.Lancet1995
Day NE, Duffy SW Surrogate markers in AIDS and cancer trials.. vol.14, (23) 2619 - 2620.
10.1002/sim.4780142310
Stat Med1995
Bashir SA, Duffy SW Correction of risk estimates for measurement error in epidemiology.. vol.34, (5) 503 - 510.Methods Inf Med1995
Duffy SW, Tabar L Screening for breast cancer.. vol.346, (8978) 852.
10.1016/S0140-6736(95)91674-1
Lancet1995
Warren RM, Duffy SW Comparison of single reading with double reading of mammograms, and change in effectiveness with experience.. vol.68, (813) 958 - 962.
10.1259/0007-1285-68-813-958
Br J Radiol1995
Andrieu N, Duffy SW, Rohan TE, Lê MG, Luporsi E, Gerber M, Renaud R, Zaridze DG, Lifanova Y, Day NE Familial risk, abortion and their interactive effect on the risk of breast cancer--a combined analysis of six case-control studies.. vol.72, (3) 744 - 751.
10.1038/bjc.1995.404
Br J Cancer1995
Duffy SW, Chen HH, Tabar L, Day NE Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase.. vol.14, (14) 1531 - 1543.
10.1002/sim.4780141404
Stat Med1995
Estève J, Parker L, Roy P, Herrmann F, Duffy S, Frappaz D, Lasset C, Hill C, Sancho-Garnier H, Michaelis J Is neuroblastoma screening evaluation needed and feasible?. vol.71, (6) 1125 - 1131.
10.1038/bjc.1995.219
Br J Cancer1995
Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, Smith RA Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.. vol.75, (10) 2507 - 2517.
10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H
Cancer1995
Cheng KK, Duffy SW, Day NE, Lam TH, Chung SF, Badrinath P Stopping drinking and risk of oesophageal cancer.. vol.310, (6987) 1094 - 1097.
10.1136/bmj.310.6987.1094
BMJ1995
Day NE, Tabar L, Duffy SW, Chen HH Population breast-cancer screening.. vol.345, (8953) 853.
10.1016/S0140-6736(95)92988-6
Lancet1995
Cheng KK, Duffy SW, Day NE, Lam TH Oesophageal cancer in never-smokers and never-drinkers.. vol.60, (6) 820 - 822.
10.1002/ijc.2910600616
Int J Cancer1995
Chen HH, Tabar L, Fagerberg G, Duffy SW Effect of breast cancer screening after age 65.. vol.2, (1) 10 - 14.
10.1177/096914139500200104
J Med Screen1995
Day N, McCann J, Camilleri-Ferrante C, Britton P, Hurst G, Cush S, Duffy S Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme.. vol.2, (4) 180 - 185.
10.1177/096914139500200402
J Med Screen1995
Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.. vol.2, (2) 94 - 98.
10.1177/096914139500200208
J Med Screen1995
Day NE, Duffy SW, Chen HH Survival and interim end points in breast cancer.. vol.2, (1) 57 - 58.
10.1177/096914139500200118
J Med Screen1995
Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE Preserved foods and nasopharyngeal carcinoma: a case-control study among Singapore Chinese.. vol.59, (5) 585 - 590.
10.1002/ijc.2910590502
Int J Cancer1994
Sankaranarayanan R, Varghese C, Duffy SW, Padmakumary G, Day NE, Nair MK A case-control study of diet and lung cancer in Kerala, south India.. vol.58, (5) 644 - 649.
10.1002/ijc.2910580505
Int J Cancer1994
Duffy SW, Sharples LD Misinterpretation of published results.. vol.89, (6) 756 - 761.
10.1111/j.1360-0443.1994.tb00962.x
Addiction1994
Ewertz M, Duffy SW Incidence of female breast cancer in relation to prevalence of risk factors in Denmark.. vol.56, (6) 783 - 787.
10.1002/ijc.2910560604
Int J Cancer1994
Duffy SW, Rohan TE, McLaughlin JR Design and analysis considerations in a cohort study involving repeated measurement of both exposure and outcome: the association between genital papillomavirus infection and risk of cervical intraepithelial neoplasia.. vol.13, (4) 379 - 390.
10.1002/sim.4780130405
Stat Med1994
Duffy SW Risk-factor epidemiology.. vol.343, (8894) 421.
10.1016/S0140-6736(94)91258-0
Lancet1994
Tabar L, Duffy SW, Burhenne LW New Swedish breast cancer detection results for women aged 40-49.. vol.72, (4 Suppl) 1437 - 1448.
10.1002/1097-0142(19930815)72:4+<1437::AID-CNCR2820721405>3.0.CO;2-M
Cancer1993
Zaridze DG, Marochko A, Basieva T, Duffy SW Cancer incidence in the native peoples of far eastern Siberia.. vol.54, (6) 889 - 894.
10.1002/ijc.2910540602
Int J Cancer1993
Zaridze DG, Arkadieva MA, Day NE, Duffy SW Risk of leukaemia after chemotherapy in a case-control study in Moscow.. vol.67, (2) 347 - 350.
10.1038/bjc.1993.63
Br J Cancer1993
Duffy SW, Maximovitch DM, Day NE External validation, repeat determination, and precision of risk estimation in misclassified exposure data in epidemiology.. vol.46, (6) 620 - 624.
10.1136/jech.46.6.620
J Epidemiol Community Health1992
Tabár L, Fagerberg G, Day NE, Duffy SW The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumor characteristics.. vol.39, (9) 846.Pathol Biol (Paris)1992
Zaridze D, Mukeria A, Duffy S Risk factors for skin melanoma in Moscow.. vol.52, (1) 159 - 161.
10.1002/ijc.2910520128
Int J Cancer1992
Zaridze DG, Basieva T, Kabulov M, Day NE, Duffy SW Oesophageal cancer in the Republic of Karakalpakstan.. vol.21, (4) 643 - 648.
10.1093/ije/21.4.643
Int J Epidemiol1992
Lee HP, Gourley L, Duffy SW, Estève J, Lee J, Day NE Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore.. vol.3, (4) 313 - 322.
10.1007/BF00146884
Cancer Causes Control1992
Cheng KK, Day NE, Duffy SW, Lam TH, Fok M, Wong J Pickled vegetables in the aetiology of oesophageal cancer in Hong Kong Chinese.. vol.339, (8805) 1314 - 1318.
10.1016/0140-6736(92)91960-G
Lancet1992
Tabár L, Fagerberg G, Day NE, Duffy SW, Kitchin RM Breast cancer treatment and natural history: new insights from results of screening.. vol.339, (8790) 412 - 414.
10.1016/0140-6736(92)90090-P
Lancet1992
Duffy SW, South MC, Day NE Cluster randomization in large public health trials: the importance of antecedent data.. vol.11, (3) 307 - 316.
10.1002/sim.4780110304
Stat Med1992
Zaridze D, Filipchenko V, Kustov V, Serdyuk V, Duffy S Diet and colorectal cancer: results of two case-control studies in Russia.. vol.29A, (1) 112 - 115.
10.1016/0959-8049(93)90586-5
Eur J Cancer1992
Qizilbash N, Duffy SW, Warlow C, Mann J Lipids are risk factors for ischaemic stroke: Overview and review. vol.2, (3) 127 - 136.
10.1159/000109004
Cerebrovascular Diseases1992
Tabàr L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O Update of the Swedish two-county program of mammographic screening for breast cancer.. vol.30, (1) 187 - 210.Radiol Clin North Am1992
Duffy SW, Tabar L, Fagerberg G, Gad A, Gröntoft O, South MC, Day NE Breast screening, prognostic factors and survival--results from the Swedish two county study.. vol.64, (6) 1133 - 1138.
10.1038/bjc.1991.477
Br J Cancer1991
Paci E, Duffy SW Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986).. vol.20, (4) 852 - 858.
10.1093/ije/20.4.852
Int J Epidemiol1991
Sankaranarayanan R, Duffy SW, Padmakumary G, Nair SM, Day NE, Padmanabhan TK Risk factors for cancer of the oesophagus in Kerala, India.. vol.49, (4) 485 - 489.
10.1002/ijc.2910490402
Int J Cancer1991
Zaridze D, Lifanova Y, Maximovitch D, Day NE, Duffy SW Diet, alcohol consumption and reproductive factors in a case-control study of breast cancer in Moscow.. vol.48, (4) 493 - 501.
10.1002/ijc.2910480404
Int J Cancer1991
Lee HP, Gourley L, Duffy SW, Estéve J, Lee J, Day NE Dietary effects on breast-cancer risk in Singapore.. vol.337, (8751) 1197 - 1200.
10.1016/0140-6736(91)92867-2
Lancet1991
Qizilbash N, Duffy SW, Rohan TE Repeat measurement of case-control data: correcting risk estimates for misclassification due to regression dilution of lipids in transient ischemic attacks and minor ischemic strokes.. vol.133, (8) 832 - 838.
10.1093/oxfordjournals.aje.a115963
Am J Epidemiol1991
Sankaranarayanan R, Duffy SW, Padmakumary G, Day NE, Krishan Nair M Risk factors for cancer of the buccal and labial mucosa in Kerala, southern India.. vol.44, (4) 286 - 292.
10.1136/jech.44.4.286
J Epidemiol Community Health1990
Ewertz M, Duffy SW, Adami HO, Kvåle G, Lund E, Meirik O, Mellemgaard A, Soini I, Tulinius H Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries.. vol.46, (4) 597 - 603.
10.1002/ijc.2910460408
Int J Cancer1990
Duffy SW, Rohan TE, Altman DG The authors reply. vol.132, (1) 198 - 199.
10.1093/oxfordjournals.aje.a115636
American Journal of Epidemiology1990
Sankaranarayanan R, Duffy SW, Nair MK, Padmakumary G, Day NE Tobacco and alcohol as risk factors in cancer of the larynx in Kerala, India.. vol.45, (5) 879 - 882.
10.1002/ijc.2910450517
Int J Cancer1990
Negri E, La Vecchia C, Duffy SW, Bruzzi P, Parazzini F, Day NE Age at first and second births and breast cancer risk in biparous women.. vol.45, (3) 428 - 430.
10.1002/ijc.2910450308
Int J Cancer1990
Tabár L, Fagerberg G, Duffy SW, Day NE [The WE project: mammography significantly decreases breast cancer mortality].. vol.87, (1-2) 36 - 39.Lakartidningen1990
Tabar L, Duffy SW, Day NE Screening with mammography.. vol.6, (3) 498 - 500.
10.1017/S0266462300001082
Int J Technol Assess Health Care1990
Duffy SW, Rohan TE, Day NE Misclassification in more than one factor in a case-control study: a combination of Mantel-Haenszel and maximum likelihood approaches.. vol.8, (12) 1529 - 1536.
10.1002/sim.4780081213
Stat Med1989
Sankaranarayanan R, Duffy SW, Day NE, Nair MK, Padmakumary G A case-control investigation of cancer of the oral tongue and the floor of the mouth in southern India.. vol.44, (4) 617 - 621.
10.1002/ijc.2910440410
Int J Cancer1989
Sankaranarayanan R, Duffy SW, Padmakumary G, Day NE, Padmanabhan TK Tobacco chewing, alcohol and nasal snuff in cancer of the gingiva in Kerala, India.. vol.60, (4) 638 - 643.
10.1038/bjc.1989.330
Br J Cancer1989
Duffy SW, Rohan TE, Altman DG A method for combining matched and unmatched binary data. Application to randomized, controlled trials of photocoagulation in the treatment of diabetic retinopathy.. vol.130, (2) 371 - 378.
10.1093/oxfordjournals.aje.a115343
Am J Epidemiol1989
Lee HP, Gourley L, Duffy SW, Estève J, Lee J, Day NE Colorectal cancer and diet in an Asian population--a case-control study among Singapore Chinese.. vol.43, (6) 1007 - 1016.
10.1002/ijc.2910430609
Int J Cancer1989
Tabar L, Fagerberg G, Duffy SW, Day NE The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.. vol.43, (2) 107 - 114.
10.1136/jech.43.2.107
J Epidemiol Community Health1989
Tabár L, Duffy S Malmö mammographic screening trial.. vol.298, (6665) 48 - 49.
10.1136/bmj.298.6665.48-d
BMJ1989
Lee HP, Duffy SW, Day NE, Shanmugaratnam K Recent trends in cancer incidence among Singapore Chinese.. vol.42, (2) 159 - 166.
10.1002/ijc.2910420204
Int J Cancer1988
Ewertz M, Duffy SW Risk of breast cancer in relation to reproductive factors in Denmark.. vol.58, (1) 99 - 104.
10.1038/bjc.1988.172
Br J Cancer1988
Gourley L, Duffy SW, Lee HP, Walker AM, Day NE A survey of household food purchases and dietary habits in relation to affluence among Singapore Chinese.. vol.42, (4) 333 - 343.Eur J Clin Nutr1988
Kennedy CR, Duffy SW, Smith R, Robinson RO Clinical predictors of outcome in encephalitis.. vol.62, (11) 1156 - 1162.
10.1136/adc.62.11.1156
Arch Dis Child1987
Tabar L, Duffy SW, Krusemo UB Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening.. vol.23, (7) 959 - 962.
10.1016/0277-5379(87)90341-5
Eur J Cancer Clin Oncol1987
Duffy SW, Tabar L Screening for breast cancer.. vol.40, (9) 907 - 910.
10.1016/0021-9681(87)90192-5
J Chronic Dis1987
Stephens S, Duffy SW, Page C A longitudinal study of gamma-interferon production by peripheral blood mononuclear cells from breast- and bottle-fed infants.. vol.65, (2) 396 - 400.Clin Exp Immunol1986
Stephens S, Brenner MK, Duffy SW, Lakhani PK, Kennedy CR, Farrant J The effect of breast-feeding on proliferation by infant lymphocytes in vitro.. vol.20, (3) 227 - 231.
10.1203/00006450-198603000-00006
Pediatr Res1986
Armstrong CP, Dixon JM, Duffy SW, Elton RA, Taylor TV, Davies GC Choledochotomy and sepsis in benign biliary disease.. vol.30, (6) 343 - 347.J R Coll Surg Edinb1985
Hickman RE, Cawson RA, Duffy SW The prognosis of specific types of salivary gland tumors.. vol.54, (8) 1620 - 1624.
10.1002/1097-0142(19841015)54:8<1620::AID-CNCR2820540824>3.0.CO;2-I
Cancer1984
Dixon JM, Armstrong CP, Duffy SW, Chetty U, Davies GC A randomized prospective trial comparing the value of intravenous and preincisional cefamandole in reducing postoperative sepsis after operations upon the gastrointestinal tract.. vol.158, (4) 303 - 307.Surg Gynecol Obstet1984
Muir BB, Kirkpatrick AE, Roberts MM, Duffy SW Oblique-view mammography: adequacy for screening. Work in progress.. vol.151, (1) 39 - 41.
10.1148/radiology.151.1.6701330
Radiology1984
Armstrong CP, Dixon JM, Duffy SW, Elton RA, Davies GC Wound healing in obstructive jaundice.. vol.71, (4) 267 - 270.
10.1002/bjs.1800710405
Br J Surg1984
Dixon JM, Armstrong CP, Duffy SW, Elton RA, Davies GC Upper gastrointestinal bleeding. A significant complication after surgery for relief of obstructive jaundice.. vol.199, (3) 271 - 275.
10.1097/00000658-198403000-00004
Ann Surg1984
Dixon JM, Armstrong CP, Duffy SW, Elton RA, Davies GC Factors affecting mortality and morbidity after surgery for obstructive jaundice.. vol.25, (1) 104.
10.1136/gut.25.1.104
Gut1984
Duffy SW, Roberts MM, Elton RA Risk factors relevant to cystic breast disease: a case-control study.. vol.37, (4) 271 - 273.
10.1136/jech.37.4.271
J Epidemiol Community Health1983
Elton RA, Duffy SW Correcting for the effect of misclassification bias in a case-control study using data from two different questionnaires.. vol.39, (3) 659 - 663.
10.2307/2531093
Biometrics1983
Dixon JM, Armstrong CP, Duffy SW, Davies GC Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients.. vol.24, (9) 845 - 852.
10.1136/gut.24.9.845
Gut1983
Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW, Stewart HJ Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease.. vol.70, (9) 513 - 516.
10.1002/bjs.1800700902
Br J Surg1983
Duffy SW, Roberts MM, Elton RA Risk factors for breast cancer: relevance to screening.. vol.37, (2) 127 - 131.
10.1136/jech.37.2.127
J Epidemiol Community Health1983
Dixon JM, Armstrong CP, Duffy SW A randomized prospective trial of preincisional and intravenous cefamandole in the prevention of post operative sepsis in patients undergoing abdominal surgery. vol.28, (1) 90.Scottish Medical Journal1983
Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW Infiltrating lobular carcinoma of the breast.. vol.6, (2) 149 - 161.
10.1111/j.1365-2559.1982.tb02712.x
Histopathology1982
Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW Authors' reply. vol.6, (6) 816 - 817.
10.1111/j.1365-2559.1982.tb02779.x
Histopathology1982
HEALEY PGT, Duffy A New Medium for Remote Music Tuition. vol.10, (1) .
10.1386/jmte.10.1.5_1
Journal of Music, Technology and Education
Brentnall AR, Duffy SW, Cuzick J Breast-Cancer Tumor Size and Screening Effectiveness.. vol.376, (1) 94.
10.1056/NEJMc1614282#SA3
N Engl J Med
Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW Impact of Screening on Breast Cancer Mortality-Response.. vol.25, (5) 873.
10.1158/1055-9965.EPI-16-0170
Cancer Epidemiol Biomarkers Prev
Duffy SW, Myles JP, MARONI R, Mohammad A Rapid review of evaluation of interventions to improve participation in cancer screening services. vol., () .
10.1177/0969141316664757
Journal of Medical Screening
Quaife SL, Ruparel M, Beeken RJ, McEwen A, Isitt J, Nolan G, Sennett K, Baldwin DR, Duffy SW, Janes SM, Wardle J The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients.. vol.16, () 281.
10.1186/s12885-016-2316-z
BMC Cancer
Bjurstam NG, Björneld LM, Duffy SW Updated results of the Gothenburg Trial of Mammographic Screening.. vol.122, (12) 1832 - 1835.
10.1002/cncr.29975
Cancer
Return to top